TW201718031A - Gel composition for ultrasound procedure and related methods - Google Patents
Gel composition for ultrasound procedure and related methods Download PDFInfo
- Publication number
- TW201718031A TW201718031A TW105137601A TW105137601A TW201718031A TW 201718031 A TW201718031 A TW 201718031A TW 105137601 A TW105137601 A TW 105137601A TW 105137601 A TW105137601 A TW 105137601A TW 201718031 A TW201718031 A TW 201718031A
- Authority
- TW
- Taiwan
- Prior art keywords
- gel composition
- agent
- humectant
- carrier
- skin
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 199
- 238000000034 method Methods 0.000 title claims abstract description 48
- 238000002604 ultrasonography Methods 0.000 title abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 73
- 239000003906 humectant Substances 0.000 claims abstract description 42
- 239000003755 preservative agent Substances 0.000 claims abstract description 38
- 239000002562 thickening agent Substances 0.000 claims abstract description 35
- 230000002335 preservative effect Effects 0.000 claims abstract description 31
- 239000002260 anti-inflammatory agent Substances 0.000 claims abstract description 22
- 229940121363 anti-inflammatory agent Drugs 0.000 claims abstract description 22
- 239000002738 chelating agent Substances 0.000 claims abstract description 20
- 230000003750 conditioning effect Effects 0.000 claims description 46
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 31
- 230000003472 neutralizing effect Effects 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 13
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 6
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 6
- 229920002125 Sokalan® Polymers 0.000 claims description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
- 229960002216 methylparaben Drugs 0.000 claims description 4
- MXOAEAUPQDYUQM-UHFFFAOYSA-N chlorphenesin Chemical group OCC(O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-UHFFFAOYSA-N 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 description 142
- 210000003491 skin Anatomy 0.000 description 81
- -1 alkaline earth metal salts Chemical class 0.000 description 29
- 239000004615 ingredient Substances 0.000 description 28
- 239000001993 wax Substances 0.000 description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 23
- 239000003921 oil Substances 0.000 description 20
- 235000019198 oils Nutrition 0.000 description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 16
- 239000000284 extract Substances 0.000 description 15
- 238000002360 preparation method Methods 0.000 description 11
- 239000002253 acid Substances 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 239000004166 Lanolin Substances 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 235000019388 lanolin Nutrition 0.000 description 9
- 229940039717 lanolin Drugs 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 235000013772 propylene glycol Nutrition 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000002202 Polyethylene glycol Substances 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 8
- 229960000448 lactic acid Drugs 0.000 description 8
- 229960004063 propylene glycol Drugs 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 7
- 108010035532 Collagen Proteins 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 229940083542 sodium Drugs 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 229940069445 licorice extract Drugs 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 235000010356 sorbitol Nutrition 0.000 description 6
- 235000002961 Aloe barbadensis Nutrition 0.000 description 5
- 244000144927 Aloe barbadensis Species 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical class OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 235000011399 aloe vera Nutrition 0.000 description 5
- 229940061720 alpha hydroxy acid Drugs 0.000 description 5
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 229920005862 polyol Polymers 0.000 description 5
- 150000003077 polyols Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- 235000021360 Myristic acid Nutrition 0.000 description 4
- 241000409198 Packera aurea Species 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- 235000004626 essential fatty acids Nutrition 0.000 description 4
- 235000008524 evening primrose extract Nutrition 0.000 description 4
- 239000010475 evening primrose oil Substances 0.000 description 4
- 229940089020 evening primrose oil Drugs 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- 150000001261 hydroxy acids Chemical class 0.000 description 4
- 229940001447 lactate Drugs 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 4
- 229940045136 urea Drugs 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 3
- 241000906543 Actaea racemosa Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 229920002101 Chitin Polymers 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 229960002442 glucosamine Drugs 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 230000005484 gravity Effects 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 3
- 235000010449 maltitol Nutrition 0.000 description 3
- 239000000845 maltitol Substances 0.000 description 3
- 229940035436 maltitol Drugs 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 229960001855 mannitol Drugs 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- DGQSERIFTYSYLE-UHFFFAOYSA-M sodium 2-(2-decanoyloxypropanoyloxy)propanoate Chemical compound [Na+].CCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O DGQSERIFTYSYLE-UHFFFAOYSA-M 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 3
- 238000012285 ultrasound imaging Methods 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- UEDJPYLQEIVDLD-UHFFFAOYSA-N 3-(2-chlorophenoxy)propane-1,2-diol Chemical compound OCC(O)COC1=CC=CC=C1Cl UEDJPYLQEIVDLD-UHFFFAOYSA-N 0.000 description 2
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 208000033316 Acquired hemophilia A Diseases 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 240000001432 Calendula officinalis Species 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- RZCHTMXTKQHYDT-UHFFFAOYSA-N N-Lactoyl ethanolamine Chemical compound CC(O)C(=O)NCCO RZCHTMXTKQHYDT-UHFFFAOYSA-N 0.000 description 2
- 241000772415 Neovison vison Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 229960000250 adipic acid Drugs 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 229940094978 bis-peg-18 methyl ether dimethyl silane Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- OEUVSBXAMBLPES-UHFFFAOYSA-L calcium stearoyl-2-lactylate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O.CCCCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O OEUVSBXAMBLPES-UHFFFAOYSA-L 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960005150 glycerol Drugs 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229940074047 glyceryl cocoate Drugs 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 229940087603 grape seed extract Drugs 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 230000001329 hyperkeratotic effect Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229940049918 linoleate Drugs 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 230000001050 lubricating effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940016409 methylsulfonylmethane Drugs 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- 239000000176 sodium gluconate Substances 0.000 description 2
- 235000012207 sodium gluconate Nutrition 0.000 description 2
- 229940005574 sodium gluconate Drugs 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- FOSNFLMXYRQNAF-UHFFFAOYSA-M sodium;2-[2-(16-methylheptadecanoyloxy)propanoyloxy]propanoate Chemical compound [Na+].CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C(=O)OC(C)C([O-])=O FOSNFLMXYRQNAF-UHFFFAOYSA-M 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 229940032362 superoxide dismutase Drugs 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- RWEISEYGJSRYKT-UHFFFAOYSA-N 2-[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC1C(O)C(CO)OC1(CO)OC1(O)C(O)C(O)C(O)C(CO)O1 RWEISEYGJSRYKT-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- FVEWVVDBRQZLSJ-QTWKXRMISA-N 2-hydroxyethyl-dimethyl-[3-[[(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoyl]amino]propyl]azanium;chloride Chemical compound [Cl-].OCC[N+](C)(C)CCCNC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FVEWVVDBRQZLSJ-QTWKXRMISA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- IGUZJYCAXLYZEE-UHFFFAOYSA-N 3,4,5-trihydroxypentan-2-one Chemical compound CC(=O)C(O)C(O)CO IGUZJYCAXLYZEE-UHFFFAOYSA-N 0.000 description 1
- QMAADWNUQRXDNZ-UHFFFAOYSA-N 3-acetamidopropyl(trimethyl)azanium;chloride Chemical compound [Cl-].CC(=O)NCCC[N+](C)(C)C QMAADWNUQRXDNZ-UHFFFAOYSA-N 0.000 description 1
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- WHDZFABLYCTYDP-UHFFFAOYSA-N 5-oxopyrrolidine-2-carboxylate;tris(2-hydroxyethyl)azanium Chemical compound OC(=O)C1CCC(=O)N1.OCCN(CCO)CCO WHDZFABLYCTYDP-UHFFFAOYSA-N 0.000 description 1
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGXLVXZRPRRCRP-IDIVVRGQSA-L Adenosine 5'-phosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O QGXLVXZRPRRCRP-IDIVVRGQSA-L 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 240000005343 Azadirachta indica Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- WRMFEYQXHPWICI-GNHAGCRUSA-N C(CCCCCCC)/C(=C(/C(=O)O)CCCCCCCC)/C(=O)O.C(C=C/C(=O)OCCCCCCCC)(=O)OCCCCCCCC Chemical compound C(CCCCCCC)/C(=C(/C(=O)O)CCCCCCCC)/C(=O)O.C(C=C/C(=O)OCCCCCCCC)(=O)OCCCCCCCC WRMFEYQXHPWICI-GNHAGCRUSA-N 0.000 description 1
- AIJGHMBMMXZSMG-UHFFFAOYSA-N C(CCCCCCCCCCCCCCC(C)C)[Na] Chemical compound C(CCCCCCCCCCCCCCC(C)C)[Na] AIJGHMBMMXZSMG-UHFFFAOYSA-N 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000019492 Cashew oil Nutrition 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000233652 Chytridiomycota Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000004385 Conyza canadensis Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 235000000504 Dioscorea villosa Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 239000001653 FEMA 3120 Substances 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241001299819 Hordeum vulgare subsp. spontaneum Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- 241000226556 Leontopodium alpinum Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000013500 Melia azadirachta Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000008653 Padma 28 Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 241000212335 Perideridia gairdneri Species 0.000 description 1
- 235000019497 Pistachio oil Nutrition 0.000 description 1
- 235000003447 Pistacia vera Nutrition 0.000 description 1
- 240000006711 Pistacia vera Species 0.000 description 1
- 229920000805 Polyaspartic acid Polymers 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 244000082490 Proboscidea louisianica Species 0.000 description 1
- 235000015926 Proboscidea louisianica ssp. fragrans Nutrition 0.000 description 1
- 235000015925 Proboscidea louisianica subsp. louisianica Nutrition 0.000 description 1
- 235000019096 Proboscidea parviflora Nutrition 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 235000012377 Salvia columbariae var. columbariae Nutrition 0.000 description 1
- 240000005481 Salvia hispanica Species 0.000 description 1
- 235000001498 Salvia hispanica Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 240000003705 Senecio vulgaris Species 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 244000125380 Terminalia tomentosa Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 240000007313 Tilia cordata Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 235000004552 Yucca aloifolia Nutrition 0.000 description 1
- 235000012044 Yucca brevifolia Nutrition 0.000 description 1
- 235000017049 Yucca glauca Nutrition 0.000 description 1
- 240000005780 Yucca gloriosa Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- ZAKOWWREFLAJOT-ADUHFSDSSA-N [2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate Chemical group CC(=O)OC1=C(C)C(C)=C2OC(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-ADUHFSDSSA-N 0.000 description 1
- MGYSHRVLFLCAIH-UHFFFAOYSA-N [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl chlorate Chemical compound CC1=NC=C(COCl(=O)=O)C(CO)=C1O MGYSHRVLFLCAIH-UHFFFAOYSA-N 0.000 description 1
- VOPVRRNGCBEXNL-BYPYZUCNSA-N [dihydroxy(methyl)silyl] (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound C[Si](O)(O)OC(=O)[C@@H]1CCC(=O)N1 VOPVRRNGCBEXNL-BYPYZUCNSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229940090419 acetamidopropyl trimonium chloride Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000010477 apricot oil Substances 0.000 description 1
- 229940089116 arnica extract Drugs 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076134 benzene Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000001201 calcium disodium ethylene diamine tetra-acetate Substances 0.000 description 1
- 235000011188 calcium disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 235000010957 calcium stearoyl-2-lactylate Nutrition 0.000 description 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-L calcium;disodium;2-[2-[bis(carboxylatomethyl)azaniumyl]ethyl-(carboxylatomethyl)azaniumyl]acetate Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-L 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- FEOYLBRDNMCIHQ-UHFFFAOYSA-N carbonic acid;pyrrolidin-2-one Chemical class OC(O)=O.O=C1CCCN1 FEOYLBRDNMCIHQ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-O carboxymethyl-[3-(dodecanoylamino)propyl]-dimethylazanium Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)=O MRUAUOIMASANKQ-UHFFFAOYSA-O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000010467 cashew oil Substances 0.000 description 1
- 229940059459 cashew oil Drugs 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000010628 chamomile oil Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000014167 chia Nutrition 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 230000003098 cholesteric effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000002242 deionisation method Methods 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- RDSDRBIJHLVNSE-UHFFFAOYSA-L dilithium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Li+].[Li+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O RDSDRBIJHLVNSE-UHFFFAOYSA-L 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- ZQHKAIDDHTYINE-UHFFFAOYSA-J disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;manganese(2+) Chemical compound [Na+].[Na+].[Mn+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ZQHKAIDDHTYINE-UHFFFAOYSA-J 0.000 description 1
- RHPXYIKALIRNFA-UHFFFAOYSA-L disodium;2-[carboxylatomethyl(carboxymethyl)amino]acetate Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CC([O-])=O RHPXYIKALIRNFA-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000014134 echinacea Nutrition 0.000 description 1
- 239000010776 emu oil Substances 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- TVQGDYNRXLTQAP-UHFFFAOYSA-N ethyl heptanoate Chemical compound CCCCCCC(=O)OCC TVQGDYNRXLTQAP-UHFFFAOYSA-N 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 235000008995 european elder Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000020702 feverfew extract Nutrition 0.000 description 1
- 229940001448 feverfew extract Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 229960004198 guanidine Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- LWIGVRDDANOFTD-UHFFFAOYSA-N hydroxy(dimethyl)silane Chemical compound C[SiH](C)O LWIGVRDDANOFTD-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940055350 kiwi fruit extract Drugs 0.000 description 1
- SXQFCVDSOLSHOQ-UHFFFAOYSA-N lactamide Chemical compound CC(O)C(N)=O SXQFCVDSOLSHOQ-UHFFFAOYSA-N 0.000 description 1
- 229940099367 lanolin alcohols Drugs 0.000 description 1
- 229940118618 leontopodium alpinum extract Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940073577 lithium chloride Drugs 0.000 description 1
- 108010083821 live yeast cell derivative Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 229940088590 perfluoropolymethylisopropyl ether Drugs 0.000 description 1
- 239000012169 petroleum derived wax Substances 0.000 description 1
- 235000019381 petroleum wax Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000010471 pistachio oil Substances 0.000 description 1
- 229940082415 pistachio oil Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002189 poly(glycerol 1-O-monomethacrylate) polymer Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 108010064470 polyaspartate Proteins 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000010491 poppyseed oil Substances 0.000 description 1
- YLSUMFQEBHBMQB-OOFFSTKBSA-M potassium;(2s,3s,4s,5r,6s)-6-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-5-[(2r,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3,4-dihydrox Chemical compound [K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O YLSUMFQEBHBMQB-OOFFSTKBSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940091888 ppg-20 methyl glucose ether distearate Drugs 0.000 description 1
- 229960002847 prasterone Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 229940097319 quaternium-22 Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000004492 retinoid derivatives Chemical class 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940046000 sodium isostearoyl lactylate Drugs 0.000 description 1
- DZCAZXAJPZCSCU-UHFFFAOYSA-K sodium nitrilotriacetate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CC([O-])=O DZCAZXAJPZCSCU-UHFFFAOYSA-K 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940080352 sodium stearoyl lactylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- OGBHACNFHJJTQT-UHFFFAOYSA-M sodium;4-butoxycarbonylphenolate Chemical compound [Na+].CCCCOC(=O)C1=CC=C([O-])C=C1 OGBHACNFHJJTQT-UHFFFAOYSA-M 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229950006451 sorbitan laurate Drugs 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229960004291 sucralfate Drugs 0.000 description 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940119168 tetrahexyldecyl ascorbate Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本人發明一般係關於一種凝膠組成物,更具體地是關於一種用於超音波程序的凝膠組成物及其相關方法。 The invention in general relates to a gel composition, and more particularly to a gel composition for an ultrasonic procedure and related methods.
組成物係本項技藝人士所熟知,及已經應用於許多工業以及最終用途。這類最終用途應用的一個具體例子係,超音波程序(如超音波掃瞄)。在超音波成像期間,發射聲波的探針或換能器,係被安放在主體身體附近,而該聲波係針對多種目的來加以利用。例如,超音波成像可以被利用,以便識別或映射出病人身體的內觀,例如肌肉、肌腱、器官、胎兒等等。再者,超音波程序係逐漸地被利用來治療無關於超音波成像的皮膚病。例如,超音波程序可以用來減少皺紋、或者改良皮膚情況,如主體的臉及/或頸部。凝膠組成物係典型地用來作為該探針或換能器與皮膚之間的界面。 The compositions are well known to those skilled in the art and have been used in many industries and end uses. A specific example of such end use applications is an ultrasonic program (such as ultrasonic scanning). During ultrasound imaging, a probe or transducer that emits acoustic waves is placed near the body of the subject, and the acoustic wave is utilized for a variety of purposes. For example, ultrasound imaging can be utilized to identify or map the internal view of the patient's body, such as muscles, tendons, organs, fetuses, and the like. Furthermore, ultrasound procedures are increasingly being utilized to treat skin disorders that are not related to ultrasound imaging. For example, ultrasound procedures can be used to reduce wrinkles, or to improve skin conditions, such as the subject's face and/or neck. Gel compositions are typically used as an interface between the probe or transducer and the skin.
習知的凝膠組成物有許多缺點。例如,某些習知的凝膠組成物,因為不良的聲性而造成聲波反射,負面地影響成品影像。其他的習知凝膠組成物,未提供合適的潤滑性, 或者在曝露於周圍空氣時過早乾燥,或有令人不想要的外觀或觸感。又,某些習知的凝膠組成物,雖提供吾人想要的潤滑性,但黏度低,因而在主體身體的局部區域內難以維持,尤其是主體係處於一垂直姿勢來進行超音波程序之時。 Conventional gel compositions have a number of disadvantages. For example, some conventional gel compositions cause acoustic reflection due to poor acoustic properties, negatively affecting the finished image. Other conventional gel compositions that do not provide suitable lubricity, Or prematurely dry when exposed to ambient air, or have an unpleasant appearance or feel. Moreover, some conventional gel compositions, while providing the lubricity desired by us, have low viscosity and are therefore difficult to maintain in a localized area of the body, especially in the vertical position of the main system for ultrasonic processing. Time.
本發明提供一種用於超音波程序的凝膠組成物。該凝膠組成物包括:(a)一載體,含量為70~95重量百分比(wt%);(b)一螫合劑,含量為大於0至0.1wt%;(c)一抗發炎劑,含量為大於0至0.3wt%;(d)一稠化劑,含量為大於0至1.0wt%;(e)一皮膚調理劑,含量為大於0至25wt%;(f)一保濕劑,含量為大於0至25wt%;(g)一防腐劑,含量為大於0至4wt%;及(h)一中和劑,含量為大於0至1wt%,上述每一含量係以該凝膠組成物總重做為基礎計算。 The present invention provides a gel composition for an ultrasonic procedure. The gel composition comprises: (a) a carrier in an amount of 70 to 95% by weight (wt%); (b) a chelating agent in an amount of more than 0 to 0.1% by weight; (c) an anti-inflammatory agent, content Is greater than 0 to 0.3 wt%; (d) a thickening agent, the content is greater than 0 to 1.0 wt%; (e) a skin conditioning agent, the content is greater than 0 to 25 wt%; (f) a humectant, the content is More than 0 to 25 wt%; (g) a preservative in an amount of more than 0 to 4 wt%; and (h) a neutralizer in an amount of more than 0 to 1 wt%, each of which is based on the total gel composition Redo as a basis for calculations.
本發明也提供一種用於製備該凝膠組成物的方法(製備方法)。該製備方法包括:組合至少該(a)載體,(b)螫合劑,(c)抗發炎劑,(d)稠化劑,(e)皮膚調理劑,(f)保濕劑,(g)防腐劑;及(h)中和劑,以便製備該凝膠組成物。 The present invention also provides a method (preparation method) for preparing the gel composition. The preparation method comprises: combining at least the (a) carrier, (b) a chelating agent, (c) an anti-inflammatory agent, (d) a thickening agent, (e) a skin conditioning agent, (f) a moisturizing agent, (g) preservative And (h) a neutralizing agent to prepare the gel composition.
又,本發明提供一種應用該凝膠組成物於超音波程序的方法(應用方法)。該應用方法包括:在主體皮膚上施加該凝膠組成物。 Further, the present invention provides a method (application method) for applying the gel composition to an ultrasonic program. The method of application comprises applying the gel composition to the skin of the subject.
揭示一種用於超音波程序的凝膠組成物,連同其製備方法、及其在主體皮膚上的應用方法。該凝膠組成物具有優良的物理性質,包括聲學性質,因而非常適合用於超音波程序。例如,該凝膠組成物可以被使用在主體皮膚之上,位於皮膚及探針或換能器之間的界面。然而,該凝膠組成物亦適合於其他與超音波程序分離的最終用途,及不局限於該最終用途或應用。 A gel composition for an ultrasonic procedure is disclosed, along with methods for its preparation, and methods of use thereof on the subject's skin. The gel composition has excellent physical properties, including acoustic properties, and is therefore well suited for use in ultrasonic procedures. For example, the gel composition can be applied over the skin of the subject, at the interface between the skin and the probe or transducer. However, the gel composition is also suitable for other end uses that are separate from the ultrasonic procedure and is not limited to this end use or application.
該凝膠組成物包括(a)一載體,其一般係該凝膠組成物的主成份。該(a)載體係該凝膠組成物成份的載具,及可以是任何的載體,其可用於承載,或者是部份地溶液化,或者是溶液化,或與該凝膠組成物的成份加以混合。在具體實施例中,該載體包括水。除了水之外,該凝膠組成物還可以包括水以外的載體,亦即,不同載體的組合。在其他實施例中,該(a)載體係水。 The gel composition comprises (a) a carrier which is generally the main component of the gel composition. The (a) carrier is a carrier for the composition of the gel composition, and may be any carrier which can be used for carrying, or partially solubilized, or solubilized, or with the composition of the gel composition. Mix it. In a particular embodiment, the carrier comprises water. In addition to water, the gel composition may also comprise a carrier other than water, that is, a combination of different carriers. In other embodiments, the (a) carrier is water.
當該(a)載體係包括水之時,凝膠組成物(a)載體的水份,係可得自任一來源,及可選擇地加以淨化。例如,該水份可來自天然來源、自來水來源等等。淨化方法的例子包含,過濾、蒸餾、去離子化、去礦物質化、逆滲透方法等等。典型地,凝膠組成物的水份係加以淨化,以便自其中移除可察覺的污染物。 When the (a) carrier comprises water, the moisture of the gel composition (a) carrier can be obtained from any source and optionally purified. For example, the moisture can be from natural sources, tap water sources, and the like. Examples of the purification method include filtration, distillation, deionization, demineralization, reverse osmosis, and the like. Typically, the moisture of the gel composition is purified to remove perceptible contaminants therefrom.
該凝膠組成物中(a)載體的含量係以該凝膠組成 物總重做為基礎計算之約70~95,或72~93,或74~91,或76~89,或78~87,或80~85重量百分比(wt%)。該凝膠組成物中(a)載體的含量係可基於凝膠組成物內的其他成份(包含可選用成份)的選用或相對數量而加以變動。 The content of the (a) carrier in the gel composition is composed of the gel The total weight is calculated based on about 70 to 95, or 72 to 93, or 74 to 91, or 76 to 89, or 78 to 87, or 80 to 85 weight percent (wt%). The amount of (a) carrier in the gel composition can be varied based on the choice or relative amount of other ingredients (including optional ingredients) within the gel composition.
該凝膠組成物進一步包括(b)一螫合劑。不同螫合劑的組合也可以共同地使用,作為(b)螫合劑。該凝膠組成物的(b)螫合劑並未加以限制。 The gel composition further comprises (b) a chelating agent. Combinations of different chelating agents can also be used in combination as (b) chelating agents. The (b) chelating agent of the gel composition is not limited.
該(b)螫合劑一般對於可能出現在該凝膠組成物內的金屬離子加以隔絕,例如(a)載體中本有的額定量者,或透過其他成份引介者、或存在於該凝膠組成物成型時周圍環境中者。合適的螫合劑的具體例子包含鹼金屬及/或鹼土族金屬鹽類,如乙二胺四乙酸的鹽類及/或次氮基三乙酸鹽(ethylene diamin tetraacetic acid及/或nitrilotria acetate)。具體物種包含EDTA鈉;EDTA二鈉;EDTA四鈉;EDTA二鋰;EDTA銫;EDTA二鈉錳;EDTA二鈉鈣;次氮基三乙酸鈉;次氮基三乙酸二鈉等等。不同螫合劑的組合,也能夠共同使用。在一實施例中,該(b)螫合劑包括EDTA二鈉。 The (b) chelating agent generally isolates metal ions that may be present in the gel composition, such as (a) the nominal amount of the carrier, or the introduction of the other component, or the presence of the gel. The person in the surrounding environment when the object is molded. Specific examples of suitable chelating agents include alkali metal and/or alkaline earth metal salts such as salts of ethylenediaminetetraacetic acid and/or ethylene diamin tetraacetic acid and/or nitrilotria acetate. Specific species include sodium EDTA; disodium EDTA; tetrasodium EDTA; dilithium EDTA; EDTA®; disodium manganese EDTA; calcium disodium EDTA; sodium nitrilotriacetate; disodium nitrilotriacetate and the like. Combinations of different chelating agents can also be used together. In one embodiment, the (b) chelating agent comprises disodium EDTA.
該(b)螫合劑在該凝膠組成物中的含量,係以該凝膠組成物總重為基礎計算之大於0至0.1、或0.1~0.9、或0.2~0.8、或0.3~0.7、或0.4~0.6wt%。該凝膠組成物中(b)螫合劑的數量,係可基於凝膠組成物內的其他成份(包含可選用成份)的選用或相對數量而加以變動。 The content of the (b) chelating agent in the gel composition is greater than 0 to 0.1, or 0.1 to 0.9, or 0.2 to 0.8, or 0.3 to 0.7, based on the total weight of the gel composition, or 0.4~0.6wt%. The amount of (b) chelating agent in the gel composition can be varied based on the choice or relative amount of other ingredients (including optional ingredients) within the gel composition.
再者,該凝膠組成物包括(c)抗發炎劑。不同抗發炎劑的組合,也可共同使用來作為該(c)抗發炎劑。適用於該凝膠組成物的抗發炎劑的例子包含:蘆薈(aloe vera)、二甲基碸(methylsulfonylmethane,MSM)、鴯鶓油(emu oil)、軟骨素(chondroitin)、葡萄糖胺(glucosamine)、類辣椒素(capsaicinoid)、山金車提取物(arnica extract)、葡萄籽提取物(grape seed extract)、芫荽油(coriander oil)、金盞花提取物(marigold extract)、蕁麻葉提取物(nettle leaf extract)、羅馬甘菊油(Roman chamomile oil)、肉蠅提取物(blue-bottle extract)、聖約翰草(St.John’s wort)、柳樹皮提取物(willow bark extract)、金縷梅提取物(witch hazel extract)、小白菊提取物(feverfew extract)、大麥草(barley grass)、黑升麻(black cohosh)、北美升麻(black snakeroot)、美洲升麻(bugbane)、美洲列當(squawroot)、乳香(Boswellia)、琉璃苣(borage)、鳳梨蛋白酶(bromelain)、牛蒡(burdock)、金盞花(calendula)、辣椒(cayenne)、水仙(dandelion)、南非鈎麻(devil’s claw root)、脫氫表雄酮(DHEA,dehydroepiandrosterone)、松果(Echinacea)、接骨木花(elderflower)、月見草油(evening primrose oil)、亞麻籽(flaxseed)、銀杏(ginko)、薑(ginger)、人蔘(gingseng)、山植(Hawthorne)、山柰酚(kaempferol)、甘草(licorice)(如甘草提取物)、活根草(life root)、金色千里光(golden Senecio)、雜草(squaw weed)、金色千里光(golden groundsel)、小白酒草 (cocash weed)、咳嗽草(coughweed)、千里光(ragwort)、金色千里光(golden ragwort)、蠹蟲屬雜草(grundy swallow)、椴(linden)、墨角蘭(marj oram)、繡線菊(meadow sweet)、正二氫癒創酸(NDGA)、印度苦楝(neem)、蓮花28(Padma 28)、槲皮素(quercetin)、乳油木(shea butter)、薑黃(turmeric)、野山藥(wild yam)、青蒿(wormwood)、絲蘭(yucca)、紅沒藥醇(bisabolol)、硫糖鋁(sucralfate)、辛醯甘胺酸(LIPACIDE)、癒創烯(guaiazulene)、必需脂肪酸、植物種子油及其他蔬菜來源的聚不飽和脂肪酸衍生物,或任何其他的抗發炎劑。必需脂肪酸(EFAs)可包含ω-3及ω-6脂肪酸,例如亞麻酸(linolenic acid)α亞麻酸。此外,任何已知含有EFAs的雜草或各種藥劑,也可以包含在該凝膠組成物內,作為該(c)抗發炎劑。這類雜草的例子包含亞麻籽及月見草油。 Further, the gel composition includes (c) an anti-inflammatory agent. Combinations of different anti-inflammatory agents can also be used together as the (c) anti-inflammatory agent. Examples of anti-inflammatory agents suitable for use in the gel composition include: aloe vera, methylsulfonylmethane (MSM), emu oil, chondroitin, glucosamine , capsaicinoid, arnica extract, grape seed extract, coriander oil, marigold extract, nettle leaf extract Extract), Roman chamomile oil, blue-bottle extract, St. John's wort, willow bark extract, witch hazel extract Witch hazel extract), feverfew extract, barley grass, black cohosh, black snakeroot, bugbane, squawroot , Boswellia, borage, bromelain, burdock, calendula, cayenne, dandelion, devil's claw root, dehydrogenation table Androsterone (DHEA, dehydroepiandroste Rone), Echinacea, elderflower, evening primrose oil, flaxseed, ginko, ginger, gingseng, Hawthorne ), kaempferol, licorice (such as licorice extract), life root, golden Senecio, squaw weed, golden groundsel , cocash weed, coughweed, ragwort, golden ragwort, grundy swallow, linden, marj oram , meadow sweet, n-dihydroguaiac acid (NDGA), neem, nep 28, Padma 28, quercetin, shea butter, turmeric, Wild yam, wormwood, yucca, bisabolol, sucralfate, lipo-glycine (LIPACIDE), guaiazulene, Essential fatty acids, plant seed oils and other vegetable-derived polyunsaturated fatty acid derivatives, or any other anti-inflammatory agent. Essential fatty acids (EFAs) may comprise omega-3 and omega-6 fatty acids, such as linolenic acid alpha linolenic acid. Further, any weeds or various agents known to contain EFAs may be contained in the gel composition as the (c) anti-inflammatory agent. Examples of such weeds include flaxseed and evening primrose oil.
在具體實施例中,該凝膠組成物的(c)抗發炎劑包括一甘草提取物。在本文中,”甘草提取物”係指任何甘草屬(即Glycyrrhizaglabra)植物中的化合物、或化合物的混合物,包含甘草、甘草次酸(glycerrhetic acid,也稱為甘草次酸(enoxolon)、烏拉爾甘草酸(uralenic acid))、甘草酸(glycyrrhizic acid,也稱為甘草甜素(glycyrrhizin)、甘草酸(glycyrrhetinic acid)、及甘草甜蜜(glycerrhtic acid glycoside))、其衍生物及其組合物。具體的甘草提取物衍生物的例子包括鹽類(如金屬鹽、銨鹽及相似類等等)及酯類(如飽和脂肪酸酯、不飽和脂肪 酸酯、二酸半酯、酸苷酯及相似類等等)。 In a particular embodiment, the (c) anti-inflammatory agent of the gel composition comprises a licorice extract. As used herein, "licorice extract" refers to any compound, or mixture of compounds, of the genus Glycyrrhiza glabra, comprising licorice, glycerrhetic acid (also known as enoxolon, ural licorice). (uralenic acid), glycyrrhizic acid (also known as glycyrrhizin acid, glycyrrhetinic acid, and glycerrhtic acid glycoside), derivatives thereof, and combinations thereof. Specific examples of the licorice extract derivatives include salts (such as metal salts, ammonium salts, and the like) and esters (such as saturated fatty acid esters, unsaturated fatty acid esters, diacid half esters, acid esters, and Similar classes, etc.).
在某些實施例中,該(c)抗發炎劑包括甘草提取物酯衍生物,例如飽和及/或不飽和的甘草次酸及甘草酸的酯類。可供使用於凝膠組成物中的代表性甘草提取物酯類衍生物,包含甘草酸單銨(monoammonium glycyrrhizinate)、甘草酸單鉀(monopotassium glycyrrhizinate)、甘草酸二鉀(dipotassium glycyrrhizinate)、1-β-甘草次酸(1-beta-glycyrrhetic acid)、甘草次酸十八酯(stearyl glycyrrhetinate)、3-十二烷氧基-甘草酸(3-stearyloxy-glycrrhetinic acid)、3-十二烷氧基-β-甘草酸鈉(disodium 3-succinyloxy-beta-glycryyhetinate)及其組合。在一實施例中,該(c)抗發炎劑包括甘草酸二鉀。 In certain embodiments, the (c) anti-inflammatory agent comprises a licorice extract ester derivative, such as a saturated and/or unsaturated glycyrrhetic acid and an ester of glycyrrhizic acid. A representative licorice extract ester derivative for use in a gel composition, comprising monoammonium glycyrrhizinate, monopotassium glycyrrhizinate, dipotassium glycyrrhizinate, 1- 1-beta-glycyrrhetic acid, stearyl glycyrrhetinate, 3-stearyloxy-glycrrhetinic acid, 3-dodecyloxy Disodium 3-succinyloxy-beta-glycryyhetinate and combinations thereof. In one embodiment, the (c) anti-inflammatory agent comprises dipotassium glycyrrhizinate.
該(c)抗發炎劑在凝膠組成物中的含量係以該凝膠組成物總重做為基礎計算的大於0至0.3wt%、或0.01~0.3wt%。類似於其他成份的是,該凝膠組成物中(c)抗發炎劑的數量,係可基於多種因子而加以變動,包含其選用、及多種可選用成份之有或無。 The (c) anti-inflammatory agent is contained in the gel composition in an amount of more than 0 to 0.3% by weight, or 0.01 to 0.3% by weight based on the total weight of the gel composition. Similar to the other ingredients, the amount of (c) anti-inflammatory agent in the gel composition can be varied based on a variety of factors, including its choice, and the presence or absence of a variety of optional ingredients.
該凝膠組成物進一步包括(d)稠化劑。不同稠化劑的組合係可共同使用作為(d)稠化劑。該(d)稠化劑使凝膠組成物產生一種吾人想要的黏度、或其他的改質流變性質,以致於該凝膠組成物係一膠體。在某些實施例中,該(d)稠化劑也稱為觸變劑(thixotroping agent)。 The gel composition further comprises (d) a thickening agent. Combinations of different thickeners can be used together as (d) thickener. The (d) thickening agent causes the gel composition to produce a viscosity, or other modified rheological property, which is desired, such that the gel composition is a colloid. In certain embodiments, the (d) thickening agent is also referred to as a thixotroping agent.
該(d)稠化劑並不限制,及其一般用來增加黏度,或改變凝膠組成物的流變性質。該(d)稠化劑係可為聚合物及/或吸水性材料。適合凝膠組成物使用的稠化劑的一個例子係丙烯酸聚合物(acrylic acid polymer)。例如,該(d)稠化劑可包括可以交聯的丙烯酸的聚合物,例如與烯丙基醚交聯(allyl ether)。具體商業上可購得之稠化劑的例子包含商名CarbomerTM者,其可購自肯塔基州Covington市的Ashland公司。在一實施例中,該(d)稠化劑包括CarbomerTM 980,其可購自肯塔基州Covington市的Ashland公司。 The (d) thickener is not limited and is generally used to increase viscosity or to alter the rheological properties of the gel composition. The (d) thickening agent can be a polymer and/or a water absorbent material. An example of a thickening agent suitable for use in a gel composition is an acrylic acid polymer. For example, the (d) thickener may comprise a polymer of acrylic acid which may be crosslinked, for example, allyl ether. Examples of thickening agent available on the specific business include trade name Carbomer TM persons, which is available from the city of Covington, Kentucky Ashland company. In one embodiment, the (D) a thickening agent comprising Carbomer TM 980, commercially available from Ashland City, Covington, Kentucky company.
額外的稠化劑的例子包含丙烯醯胺共聚物(acrylamide copolymer)、丙烯酸酯共聚物(ácrylate copolymer)及其鹽類(如聚丙烯酸鈉)、黃原膠(xanthan gum)及其衍生物、纖維素膠(cellulose gum)及纖維素衍生物(例如甲基纖維素、甲基羥丙基纖維素、羥甲基纖維素、羥丙基纖維素、聚丙羥基乙基纖維素)、澱粉及澱粉衍生物(如羥甲基直鏈澱粉及澱粉酶)、聚氧化乙烯、卡波姆(carbomer)、海藻酸鈉鹽類(alginates,例如海藻酸鈉)、阿拉伯膠、肉桂膠、角豆膠、硬葡聚糖膠、結冷膠、鼠聚糖膠、刺梧桐樹膠、卡拉膠、瓜耳豆膠及瓜耳豆膠衍生物、椰油醯胺行生物(包含椰油醯胺丙基甜菜鹼”cocamidopropy betaine”、椰油醯胺異丙醇胺”cocamide MIPA”)、及其混合物。 Examples of additional thickeners include acrylamide copolymers, ácrylate copolymers and salts thereof (such as sodium polyacrylate), xanthan gum and its derivatives, and fibers. Gum (cellulose gum) and cellulose derivatives (such as methyl cellulose, methyl hydroxypropyl cellulose, hydroxymethyl cellulose, hydroxypropyl cellulose, polypropyl hydroxyethyl cellulose), starch and starch derived (such as hydroxymethyl amylose and amylase), polyethylene oxide, carbomer, sodium alginate (alginates, such as sodium alginate), gum arabic, cassia gum, locust bean gum, hard Dextran gum, gellan gum, murine gum, karaya gum, carrageenan, guar gum and guar gum derivatives, cocoamine amines (including cocoamidopropyl betaine) Cocamidopropy betaine", cocoamide MIPA"), and mixtures thereof.
在許多實施例中,該凝膠組成物中該(d)稠化劑的 含量係以該凝膠組成物總重計算的大於0至1、或0.05~1、或0.2~0.9、或0.4~0.8、或0.6~0.7wt%。類似其他成份的是,該(d)稠化劑在凝膠組成物中的相對數量,係可基於多種因子而變動。當該凝膠組成物進一步包括(h)中和劑以便中和該(d)稠化劑時,(如下文所述者),該數量係以凝膠組成物在反應前或中和前做為基礎計算。 In many embodiments, the (d) thickener of the gel composition The content is greater than 0 to 1, or 0.05 to 1, or 0.2 to 0.9, or 0.4 to 0.8, or 0.6 to 0.7 wt%, based on the total weight of the gel composition. Like other ingredients, the relative amount of the (d) thickener in the gel composition can vary based on a variety of factors. When the gel composition further comprises (h) a neutralizing agent to neutralize the (d) thickening agent (as described below), the amount is such that the gel composition is before or before the reaction. Based on calculations.
該凝膠組成物進一步包括(e)皮膚調理劑。不同皮膚調理劑的組合亦得共同使用,作為該(e)皮膚調理劑。該(e)皮膚調理劑在該凝膠組成物中可提供許多種功能,包含在凝膠組成物被施加到主體皮膚時,提供安撫性質。再者,取決於該(e)皮膚調理劑的選用,該(e)皮膚調理劑也可以具有類似於保濕劑及軟化劑的性質。 The gel composition further comprises (e) a skin conditioning agent. Combinations of different skin conditioning agents are also used in combination as the (e) skin conditioning agent. The (e) skin conditioning agent provides a number of functions in the gel composition, including providing a soothing property when the gel composition is applied to the subject's skin. Further, depending on the selection of the (e) skin conditioning agent, the (e) skin conditioning agent may also have properties similar to humectants and softeners.
該(e)皮膚調理劑亦可在皮膚上產生或保留濕氣。皮膚水份增加,可以使皮膚更加柔軟及柔順。皮膚調理劑可以用來模仿正常皮膚分泌物在維持皮膚柔軟(suppleness in the skin)方面的活動,及提供一種防止蒸發的隔離體。習知的皮膚調理劑一般包含兩種廣用型:閉塞劑類(occlusives)及保濕劑類。閉塞潤濕劑在皮膚上形成一個層體,其降低了蒸發速率。保濕劑係非閉塞性吸濕物質,其保留水份,並使水份可利用於皮膚。保濕劑也可以藉由改良皮膚潤滑性,來產生功能。 The (e) skin conditioning agent can also produce or retain moisture on the skin. Increased skin moisture can make the skin softer and supple. Skin conditioning agents can be used to mimic the activity of normal skin secretions in maintaining suppleness in the skin and to provide a barrier to evaporation. Conventional skin conditioning agents generally comprise two broad types of use: occlusives and humectants. The occlusive wetting agent forms a layer on the skin which reduces the rate of evaporation. Humectants are non-occlusive, hygroscopic substances that retain moisture and allow moisture to be applied to the skin. Humectants can also function by improving skin lubricity.
該(e)皮膚調理劑可以包含單一的潤濕成份,或可 包括多數個基於多種目的而包含進去的成份,例如軟化劑、乳化劑、類酯化合物、表面活性劑、增稠劑、及防腐劑。又,該(e)皮膚調理劑可同時具有閉塞性及軟化性。水份可以連同被保留在皮膚調理劑內的成份一起出現。被合併到該凝膠組成物內的皮膚調理劑的濃度及其類型的選擇,使其穩定性及使用時的性質沒有負作用。 The (e) skin conditioning agent may comprise a single moisturizing ingredient, or may It includes a number of ingredients that are included for a variety of purposes, such as softeners, emulsifiers, ester-like compounds, surfactants, thickeners, and preservatives. Further, the (e) skin conditioning agent can have both occlusive properties and softening properties. Moisture can occur along with the ingredients that are retained in the skin conditioning agent. The concentration of the skin conditioning agent incorporated into the gel composition and the choice of its type have no negative effect on its stability and properties at the time of use.
合適的皮膚調理劑包含長鏈C12-C22脂族酸、液態水可溶的多醇甘油類(polyols glycerin)、丙二醇(propylene glycol)、山梨糖醇(sorbital)、聚乙二醇(polyethylene glycol)、甲基纖維素的乙氧基化/丙氧基化的醚類(ethoxylated/propoxylated ethers of methyl glucose)、乙氧基化的/丙氧基化的羊毛脂醇的醚類(ethoxylated/propoxylated ethers of lanolin alcohol)、椰油酸(coconut fatty acid)、牛脂酸(tallow fatty acid)、非閉塞性液態水可溶的多醇類、濃縮蘆薈膠、蘆薈的冷凍乾燥粉末、蘆薈油提取物、胺基酸類、羊水(amniotic fluid)、梨鱷油溶劑的天然植物提取物(avocadin)、鈣蛋白複合物(calcium protein complex)、腰果油(cashew oil)、奇亞籽油(chia oil)、幾丁質(chitin)、聚葡萄糖胺(chitosan)、聚葡萄糖胺PCA鹽類(chitosan PCA)、膽固醇醚類(cholesteric esters)、硫酸軟骨膠(chondroitin sulfate)、膠原(collagen)、膠原胺基酸類(collagen amino acids)、銅蛋白複合物(copper protein complex)、馬來酸二辛酯(dioctyl maleate)、季戊四醇脂肪酸 酯(dipentaerythritol fatty acid ester)、彈性蛋白(elastin)、乙戊醇(ethyl panthenol)、月見草油、甘油醇-12(glycereth-12)、鞘糖脂類(glycosphingo lipids)、玻尿酸(hyaluronic acid)、混合紅花油(hybrid safflower oil)、氫化聚異丁烯(hydrogenated polyisobutene)、水解膠原(hydrolyzed collagen)、水解彈性蛋白(hydrolyzed elastin)、水解纖維連接蛋白(hydrolyzed fibronectin)、水解黏多糖(hydrolyzed mucopolysaccharides)、水解絲(hydrolyzed silk)、水解小麥蛋白(hydrolyzed wheat protein)、荷荷巴酯(jojoba esters)、角蛋白胺基酸類(keratin amino acids)、奇異果提取物(kiwi fruit extract)、乳醯胺MEA(lactamide MEA)、卵磷脂類(liposomes)、活性酵母菌細胞衍生物卵磷脂(live yeast cell derivative liposome)、海洋胺基多醣類(marina polyaminosaccharide)、礦油、貂油乙醚(mink oil ethyl ether)、黏多醣(mucopolysaccharides)、黏多醣(mucopolysaccharides)、棕櫚提取物(palmetto extract)、高山火絨草提取物(leontopodiumalpinum extract(小白花Edelweiss))、泛硫乙胺(pantethine)、石蠟(paraffin)、聚乙二醇-4(PEG-4)、PEG-6、PEG-8、PEG-12、聚乙二醇-100硬脂酸脂(PEG-100 stearate)、全氟聚異丙甲基醚(perfluoropolymethyl-isopropyl ether)、凡士林、凡士林蠟(petroleum wax)、開心果油(pistachio oil)、胎盤提取物(placenta extract)、浮游生物提取物(plankton extract)、多胺基 酸多醣縮合物(polyamino sugar condensate)、聚丁烯(polybutene)、甘油聚甲基丙烯酸酯(polyglyceryl methacrylate)、聚四月桂酸季戊四醇酯(polypentaerythrityltetralaurate)、聚丙二醇-10丁二醇(PPG-10 butanediol)、PPG-20甲基葡糖醚二硬酯酸酯(PPG-20 methyl glucose ether distearate)、蜂王乳提取物(royal jelly extract)、異構糖(saccharide isomerate)、硒蛋白提取物(selenium protein complex)、血清白蛋白(serum albumin)、二甲基矽烷醇透明質酸酯鈉(sodium hyaluronate dimethylsilanol)、乳酸鈉甲矽烷醇(sodium lactate methylsilonol)、甘露糖醛酸鈉甲矽烷醇(sodium mannuronatemethylsilanol)、水溶性膠原(soluble collagen)、超氧化物歧化酶(super oxide dismutase)、超氧化物歧化酶卵磷質(super oxide dismutase liposome)、組織提取物(tissue extract)、亞油酸鹽維生素E(tocopheryl linoleate)、親油性潤濕劑(lipophylic moisturizers),如溶血性卵磷脂(lysolecithin)、卵磷脂、膽固醇、谷甾醇(sitosterol)、膽固醇酯(cholesterol esters)、鞘脂類(sphingolipids)、或神經醯胺類(ceramides)、低分子量的潤濕劑,例如絲氨酸(serine)、麩氨酸(glutamine)、山梨醇、甘露醇、甘油、吡咯酮羧酸鈉(sodium pyrrolidone-carboxylate)、丁二醇、丙二醇、乳酸、或乳酸鹽類、高分子量的潤濕劑,例如玻尿酸、玻尿酸鈉(sodium hyaluronate)、彈性蛋白、海藻酸、黏多醣、聚天冬 氨酸鹽類(polyaspartic acid salts)、或水溶性幾丁質、碳氫油類(hydrocarbon oils)、碳氫蠟(hydrocarbon waxes)、矽膠類(silicones,如矽靈”dimethicone”)、雙PEG-18-甲基醚二甲基矽烷蠟(bis-PEG-18 methyl ether dimethyl silane wax)、脂肪酸衍生物、膽固醇、膽固醇衍生物、二及三甘油酯(di-and tri-glycerides)、植物油、植物油衍生物、液態不可消化性油類(liquid nondigestible oils)、液態可消化性或不可消化性油類與固態多醇聚醚的組合(combinations of liquid digestible or nondigestible oils with solid polyol polyesters)、乙醯甘油酯類(acetoglyceride esters)、烷基酯類(alkyl esters)、烯基酯類(alkenyl esters)、羊毛脂及其衍生物、牛乳甘油三酯(milk tri-glycerides)、蠟酯(wax esters)、甘油酯類及其衍生物(例如,PEG-7甘油椰油酸酯)、蜂蠟衍生物、甾醇類(sterols)、磷脂質(phospholipids)、或任何其他的皮膚調理劑。 Suitable skin conditioning agents include long chain C12-C22 aliphatic acids, liquid water soluble polyols glycerin, propylene glycol, sorbital, polyethylene glycol. Ethoxylated/propoxylated ethers of methylglucose, ethers of ethoxylated/propoxylated lanolin alcohols (ethoxylated/propoxylated ethers) Of lanolin alcohol), coconut fatty acid, tallow fatty acid, non-occlusive liquid water-soluble polyol, concentrated aloe vera gel, freeze-dried powder of aloe vera, aloe vera oil extract, amine Natural plant extract (avocadin), calcium protein complex, cashew oil, chia oil, chitin, acid, amniotic fluid, pear crocodile solvent Chitin, chitosan, chitosan PCA, cholesteric esters, chondroitin sulfate, collagen, collagen amino acids (collagen) Amino acids) Copper-protein complex (copper protein complex), dioctyl maleate (dioctyl maleate), pentaerythritol fatty acid Dipentaerythritol fatty acid ester, elastin, ethyl panthenol, evening primrose oil, glycereth-12, glycosphingo lipids, hyaluronic acid, Hybrid safflower oil, hydrogenated polyisobutene, hydrolyzed collagen, hydrolyzed elastin, hydrolyzed fibronectin, hydrolyzed mucopolysaccharides, hydrolysis Hydrolyzed silk, hydrolyzed wheat protein, jojoba esters, keratin amino acids, kiwi fruit extract, chytrid MEA Lactamide MEA), lecithins, live yeast cell derivative liposome, marine polyaminosaccharide, mineral oil, mink oil ethyl ether , mucopolysaccharides, mucopolysaccharides, palmetto extract, Leontopodiumalpinum extract (Edelweiss), pantethine, paraffin, polyethylene glycol-4 (PEG-4), PEG-6, PEG-8, PEG- 12. PEG-100 stearate, perfluoropolymethyl-isopropyl ether, petrolatum, petroleum wax, pistachio oil , placenta extract, plankton extract, polyamine Polyamino sugar condensate, polybutene, polyglyceryl methacrylate, polypentaerythrity ltetralaurate, polypropylene glycol-10 butanediol ), PPG-20 methyl glucose ether distearate, royal jelly extract, saccharide isomerate, selenium protein Complex), serum albumin, sodium hyaluronate dimethylsilanol, sodium lactate methylsilonol, sodium mannuronatemethylsilanol, Water soluble collagen, super oxide dismutase, super oxide dismutase liposome, tissue extract, linoleate vitamin E (tocopheryl) Linoleate), lipophylic moisturizers, such as lysolecithin, lecithin, gallbladder Sterols, sitosterol, cholesterol esters, sphingolipids, or ceramides, low molecular weight wetting agents such as serine, glutamine ), sorbitol, mannitol, glycerol, sodium pyrrolidone-carboxylate, butanediol, propylene glycol, lactic acid, or lactate, high molecular weight wetting agents, such as hyaluronic acid, sodium hyaluronate ), elastin, alginic acid, mucopolysaccharide, polyaster Polyaspartic acid salts, or water-soluble chitin, hydrocarbon oils, hydrocarbon waxes, silicones (dimethicone), double PEG- Bis-PEG-18 methyl ether dimethyl silane wax, fatty acid derivatives, cholesterol, cholesterol derivatives, di-and tri-glycerides, vegetable oils, vegetable oils Combinations of liquid nondigestible oils, combinations of liquid digestible or nondigestible oils with solid polyol polyesters, acetyl glycerol Acetylglyceride esters, alkyl esters, alkenyl esters, lanolin and its derivatives, milk tri-glycerides, wax esters, Glycerides and derivatives thereof (eg, PEG-7 glycerol cocoate), beeswax derivatives, sterols, phospholipids, or any other skin conditioning agent.
其他合適的皮膚調理劑的例子,如閉塞性皮膚調理劑,包含凡士林、石蠟、蠟類、油脂、礦物油、蜂蠟、羊毛脂及油溶性羊毛脂衍生物、飽和及不飽和的脂肪醇類,例如二十二醇(behenyl alcohol)、鯊烯(squalene)、多種動植物油類,例如杏仁油(almond oil)、杏核桃油(apricot oil)、杏核油(apricot pit oil)、鱷梨油(avocado oil)、杜松油(cade oil)、蓖麻油(castor oil)、肉桂油(cinnamon oil)、玉米油(corn oil)、棉籽油(cottonseed oil)、月見草油、葡萄油(grape oil)、葡萄 籽油(grape seed oil)、榛子油(hazelnut oil)、荷荷巴油、亞麻籽油(linseed oil)、肝油(liver oil)、夏威夷果油(macadamia nut oil)、貂油(mink oil)、牛腳油(neetsfoot oil)、橄欖油(olive oil)、棕櫚仁油(palm kernel oil)、棕櫚果油(palm nut oil)、棕櫚油(palm oil)、桃核油(peach pit oil)、花生油(peanut oil)、松油(pine oil)、腰果油(pistachio nut oil)、罌粟籽油(poppyseed oil)、菜籽油(rapeseed oil)、米糠油(rice bran oil)、米胚芽油(rice germ oil)、紅花油(safflower oil)、山茶花油(sasanqua oil)、芝麻油(sesame oil)、芝麻籽油(sesame seed oil)、黃豆油(soybean oil)、葵花油(sunflower oil)、葵花籽油(sunflower seed oil)、山茶油(tsubaki oil)、核桃油(walnut oil)、小麥胚芽油(wheat germ oil)、小麥芽油(wheat germ oil)、茶籽油(teaseed oil)、三酸甘油酯(triglycerine)、三辛酸甘油酯(glycerinetrioctanate)、甘油四異棕櫚酸酯(glycerinetriisopalmitate)、可可脂(cacao fat)、牛油(beef tallow)、綿羊油(sheep fat)、野豬油(hog fat)、馬油(horse fat)、氫化油(hydrogenated oil)、氫化蓖麻油(hydrogenated castor oil)、日本蠟(Japanese wax)、乳油木果油(shea butter)、蜂蠟、小燭樹蠟(candelilla wax)、棉蠟(cotton wax)、巴西棕櫚蠟(carnauba wax)、楊梅蠟(bayberry wax)、樹蠟(tree wax)、鯨蠟(spermaceti)、褐煤蠟(montan wax)、米糠蠟(bran wax)、羊毛脂、還原羊毛脂、硬羊毛脂(hard lanolin)、木棉花蠟(kapok wax)、甘蔗蠟(sugarcane wax)、荷荷巴蠟(jojoba wax)、蟲膠蠟(shellac wax)、或展現出閉塞性質的任何其他的皮膚調理劑。 Examples of other suitable skin conditioning agents, such as occlusive skin conditioning agents, include petrolatum, paraffin, waxes, oils, mineral oils, beeswax, lanolin and oil-soluble lanolin derivatives, saturated and unsaturated fatty alcohols, For example, behenyl alcohol, squalene, various animal and vegetable oils, such as almond oil, apricot oil, apricot pit oil, avocado oil ( Avocado oil), cade oil, castor oil, cinnamon oil, corn oil, cottonseed oil, evening primrose oil, grape oil, grape Grape seed oil, hazelnut oil, jojoba oil, linseed oil, liver oil, macadamia nut oil, mink oil, Neetsfoot oil, olive oil, palm kernel oil, palm nut oil, palm oil, peach pit oil, peanut oil (peanut oil), pine oil, pistachio nut oil, poppyseed oil, rapeseed oil, rice bran oil, rice germ oil Oil), safflower oil, sasanqua oil, sesame oil, sesame seed oil, soybean oil, sunflower oil, sunflower oil Sunflower seed oil), tsubaki oil, walnut oil, wheat germ oil, wheat germ oil, teaseed oil, triglyceride Triglycerine), glycerinetrioctanate, glycerinetriisopalmitate, cocoa butter (cacao f At), beef tallow, sheep fat, hog fat, horse fat, hydrogenated oil, hydrogenated castor oil, Japanese wax Japanese wax), shea butter, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, tree wax Wax), spermaceti, montan wax, bran wax, lanolin, reduced lanolin, hard lanolin, kapok wax Wax), sugarcane wax, jojoba wax, shellac wax, or any other skin conditioning agent that exhibits occlusive properties.
該(e)皮膚調理劑可包含能夠模仿植物性天然成份及功能的藥劑,包含維生素、羥酸類及類視色素(retinoids)。維生素可包含維生素A、視黃醇(retinol)、棕櫚酸視黃醇酯(retinol palmitate)、肌醇(inositol)、氯酸吡哆醇酯(pyridoxine chlorate)、煙酸苄酯(benzyl nicotinate)、煙醯胺(nicotinamide)、dlα-生育烯基尼古丁(dlα-tocopheryl nicotine)、抗壞血酸磷脂鎂(magnesium ascorbyl phosphate)、四己基葵醇抗壞血酸酯(tetrahexyldecyl ascorbate)、維生素D2(ergocalciferol)、dlα-生育酚(dlα-tocopherol)、dl-α-生育酚-2-L-抗壞血酸-二酯化鉀(potassium dl-α-tocopherol-2-L-ascorbic diester)、dl-α-生育烯基-乙酸酯(dl-α-tocopheryl acetate)、泛酸(pantothenic acid)、生物素(biotin)、或任何其他的維生素。某些可以降低嚴重乾燥皮膚的成份係(α-羥基酸類(alpha hydroxy acids“AHA”)及β-羥基酸類(beta hydroxy acids“BHA”),包含其鹽類以及類視色素。該羥基酸類係依照羧基在其結構上的數量而加以分類。單羧酸類係甘醇酸、乳酸及扁桃酸(mandelic acid)。二羧酸類包含馬來酸及酒石酸(malic and tartaric acids)。三羧酸類係由柑橘類水果(citrus fruits)中所發現的檸檬酸加以實施。BHAs 涵蓋了大部份的水楊酸(salicylic acid)及其衍生物。AHAs已經顯示去角質。因此,它們在過度角化條件(hyperkeratotic conditions)之下係有用的。皮膚調理劑的其他成份可以包含彈性蛋白、卵磷脂、玻尿酸鈉、鈉氫基吡咯烷酮(sodium passive cutaneous anaphylaxis)、神經醯胺(ceramides)、天然的皮膚脂質及甾醇類、人工合成的或天然的油類、保濕劑、軟化劑、乳化劑、防腐劑、潤滑劑、油脂、天然的潤濕因子(natural moisturizing factors“NMF”),包含低分子量的材料,例如氨(ammonia)、胺基酸(amino acids)、葡萄糖胺(glucosamine)、肌酸酐(creatinine)、檸檬酸鹽及離子溶液(citrate and ionic solutions),例如鈉、鉀、氯化物、磷酸鹽、鈣及鎂、吡咯酮羧酸鈉(sodium pyrrolidone carboxylic acid)、己二酸、乳酸、油酸、硬脂酸、異硬脂酸、肉荳蔻酸及亞麻酸的十六烷基、十四烷基、異癸烷基或異丙基酯(hexadecyl,myristyl,isodecyl,or isopropyl esters of adipic,lactic,oleic,stearic,isostearic,myristic and linoleic acids)及其相對應的醇酯、異硬脂酸基1-2-乳酸鈉(sodium isostearoyl-2-lactylate)及辛醯乳酸鈉(sodium capryllactylate)、甘油、聚乙二醇(polyethylene glycol)、聚丙二醇(propylene glycol)、山梨醇、甲基纖維素的聚乙二醇及聚丙二醇醚類(polyethylene glycol and propylene glycol ethers of methyl glucose)、羊毛脂醇、乳酸、L-脯氨酸及其他自由脂肪酸的乙二醇和丙二醇醚類(polyethylene glycol and propylene glycol ethers of lanolin alcohol,lactic acid,L-proline,and other free fatty acids)、椰油酸、牛油酸、皮膚上天然發生的非閉塞性液態水可溶的多醇及必需胺基酸化合物、以及硬脂酸與月桂酸。 The (e) skin conditioning agent may comprise an agent that mimics the natural ingredients and functions of the plant, including vitamins, hydroxy acids, and retinoids. The vitamin may comprise vitamin A, retinol, retinol palmitate, inositol, pyridoxine chlorate, benzyl nicotinate, Nicotinamide, dlα-tocopheryl nicotine, magnesium ascorbyl phosphate, tetrahexyldecyl ascorbate, ergocalciferol, dlα-tocopherol (dlα-tocopherol), dl-α-tocopherol-2-L-ascorbic acid-potassium dipotassium (potassium dl-α-tocopherol-2-L-ascorbic diester), dl-α-tocoenyl-acetate (dl-α-tocopheryl acetate), pantothenic acid, biotin, or any other vitamin. Some severely dry skin may be reduced based ingredients (α - hydroxy acids (alpha hydroxy acids "AHA") β- and hydroxy acids (beta hydroxy acids "BHA") , and salts thereof comprising the retinoid-based hydroxy acids. It is classified according to the number of carboxyl groups in its structure. Monocarboxylic acids are glycolic acid, lactic acid and mandelic acid. Dicarboxylic acids include maleic acid and tartaric acid. The citric acid found in citrus fruits is implemented. BHAs cover most salicylic acids and their derivatives. AHAs have been shown to exfoliate. Therefore, they are in hyperkeratotic conditions (hyperkeratotic) Useful under conditions. The other ingredients of skin conditioning agents may include elastin, lecithin, sodium hyaluronate, sodium passive cutaneous anaphylaxis, ceramides, natural skin lipids and sterols. , synthetic or natural oils, humectants, softeners, emulsifiers, preservatives, lubricants, greases, natural wetting factors (natural mois Turing factors "NMF"), containing low molecular weight materials such as ammonia, amino acids, glucosamine, creatinine, citrate and ionic solutions ), such as sodium, potassium, chloride, phosphate, calcium and magnesium, sodium pyrrolidone carboxylic acid, adipic acid, lactic acid, oleic acid, stearic acid, isostearic acid, myristic acid And hexadecyl, tetradecyl, isodecyl or isodecyl, or isopropyl esters of adipic, lactic, oleic, stearic, isostearic, myristic and linoleic acids Its corresponding alcohol ester, sodium isostearoyl-2-lactylate and sodium capryllactylate, glycerin, polyethylene glycol, polypropylene glycol (propylene glycol) ), sorbitol, methyl glycol and polyethylene glycol and propylene glycol ethers of methyl glucose, lanolin alcohol, lactic acid, L-valine and other free fatty acids And polyethylene glycol and propylene glycol ethers of lanolin alcohol, lactic acid, L-proline, and other free fatty acids, cocoic acid, tallow acid, naturally occurring non-occlusive liquid water soluble on the skin. Polyols and essential amino acid compounds, as well as stearic acid and lauric acid.
該(e)皮膚調理劑的含量係以該凝膠組成物總重作為基礎計算的大於0至25wt%、或5~20wt%。類似其他成份的是,該(e)皮膚調理劑在凝膠組成物中的相對數量,係可基於多種因子而變動。 The content of the (e) skin conditioning agent is greater than 0 to 25 wt%, or 5 to 20 wt%, based on the total weight of the gel composition. Like other ingredients, the relative amount of the (e) skin conditioning agent in the gel composition can vary based on a variety of factors.
在具體實施例中,該(e)皮膚調理劑包含一皮膚調理劑的組合。在這個具體實施例中,該(e)皮膚調理劑包括至少兩種(可換地是至少三種、或至少四種)不同的皮膚調理劑。例如,該(e)皮膚調理劑可包括丁二醇、化粧蠟、甘油酯及多糖體的組合物。 In a particular embodiment, the (e) skin conditioning agent comprises a combination of skin conditioning agents. In this particular embodiment, the (e) skin conditioning agent comprises at least two (alternatively at least three, or at least four) different skin conditioning agents. For example, the (e) skin conditioning agent can include a combination of butylene glycol, cosmetic wax, glyceride, and polysaccharide.
該化粧蠟可為任何合適的化粧蠟。在某些實施例中,該化粧蠟係至少部份地水可溶的或可分散的,或可替換地是,完全水可溶的或可分散的。可替換地,該化粧蠟可以與水以外的其他的可至少部份溶於或分散於該化粧蠟的載具載體,一同組合來使用。該化粧蠟可為有機的,及可額外地包含無機部份,例如鹽水部。適用於該凝膠組成份之一個示範性的化粧蠟具體例子係雙-PEG-18-甲基醚二甲基矽烷蠟(bis-PEG-18 methyl ether dimethyl silane wax)。 The cosmetic wax can be any suitable cosmetic wax. In certain embodiments, the cosmetic wax is at least partially water soluble or dispersible, or alternatively, completely water soluble or dispersible. Alternatively, the cosmetic wax may be used in combination with other carrier carriers other than water which may be at least partially dissolved or dispersed in the cosmetic wax. The cosmetic wax may be organic and may additionally comprise an inorganic portion, such as a saline portion. A specific example of an exemplary cosmetic wax suitable for use in the gel component is bis-PEG-18 methyl ether dimethyl silane wax.
該甘油酯可為(例如)PEG-7甘油椰油酸酯(PEG-7 glyceryl cocoate)。 The glyceride can be, for example, PEG-7 glycerol cocoate (PEG-7) Glyceryl cocoate).
該多糖體可自任一來源加以衍生出來,例如,碳水化合物,如山梨糖醇、葡萄糖等等的發酵。合適的多糖體之一個例子係生物糖膠-1(biosaccharide gum-1)。 The polysaccharide can be derived from any source, for example, fermentation of carbohydrates such as sorbitol, glucose, and the like. An example of a suitable polysaccharide is biosaccharide gum-1.
在這些具體實施例中,丁二醇在凝膠組成物內的含量係該凝膠組成物總重計算的1~15、或1~10、或2~6wt%。化粧蠟在凝膠組成物內的含量係該凝膠組成物總重計算的1~10、或1~7、或2~4wt%。甘油酯在凝膠組成物內的含量係該凝膠組成物總重計算的大於0至10、大於0至5、或0.5~2.5wt%。該多糖體在凝膠組成物內的含量係該凝膠組成物總重計算的1~20、或1~15、或1~10wt%。 In these embodiments, the amount of butanediol in the gel composition is from 1 to 15, or from 1 to 10, or from 2 to 6 wt%, based on the total weight of the gel composition. The content of the cosmetic wax in the gel composition is 1 to 10, or 1 to 7, or 2 to 4% by weight based on the total weight of the gel composition. The content of the glyceride in the gel composition is greater than 0 to 10, greater than 0 to 5, or 0.5 to 2.5 wt%, based on the total weight of the gel composition. The content of the polysaccharide in the gel composition is 1 to 20, or 1 to 15, or 1 to 10% by weight based on the total weight of the gel composition.
該凝膠組成物進一步包括(f)保濕劑。不同保濕劑的組合,也得以共同作為(f)保濕劑使用。凝膠組成物的保濕劑並未加以限制。該(f)保濕劑係不同於(e)皮膚調理劑,而可與之區別。 The gel composition further includes (f) a humectant. Combinations of different humectants are also commonly used as (f) humectants. The humectant of the gel composition is not limited. The (f) humectant is different from (e) a skin conditioner and can be distinguished therefrom.
合適的保濕劑的例子包含但不限於:甘油、透明質酸、山梨糖醇、尿素(urea)、α羥基酸(alpha hydroxy acids)、蔗糖(sugars)、乳酸、丙二醇、三乙酸甘油酯(glyceryl triacetate)、氯化鋰(lithium chloride)、山梨糖醇、木糖醇(xylitol)及麥芽糖醇(maltitol)之類的多醇類、聚合物多醇類(polymeric polyols)的聚葡萄糖(polydextrose)、天然提取物類的己二酸、乳酸、油酸、硬脂酸、異硬脂酸、肉豆蔻酸及亞 油酸的皂苷酯、十六酯、十四酯、異癸酯及異丙酯(quillaia,hexadecyl,myristyl,isodecyl and isopropyl esters of adipic,lactic,oleic,stearic,isostearic,myristic and linoleic acids)以及其許多相對應的醇酯類(例如異硬脂酸醯基-2-乳酸酯鈉”sodium isostearoyl-2-lactylate”、癸醯乳醯乳酸鈉“sodium capryllactylate”)、水解的蛋白質及其他膠原衍生性蛋白質、蘆薈膠、乙醯基MEA、皮膚角質層上天然發生的化合物,例如吡咯烷酮羧酸鈉(sodium pyrrolidone carboxylic acid)、乳酸、尿素、L-脯氨酸、胍(guanidine)及吡咯烷酮(pyrrolidone)、乙醯基MEA、氯化乙醯氨基丙基三銨(acetamido propyl trimonium chloride)、乳醯化硬脂酸鈣(calcium stearoyllactylate)、幾丁吡咯烷酮羧酸(chitosan pyrrolidone carboxylic acid”PCA”)、二甘油乳酸酯(diglycerol lactate)、水解絲的乙酯(ethyl ester of hydrolyzed silk)、脂族基氯化季銨鹽複合物(fatty quaternary amine chloride complex)、甘油醇-7(glycereth-7)、甘油醇-12、甘油醇-26、甘油醇-4.5乳酸酯(glycereth-4.5 lactate)、甘油、二甘油(diglycerin)、多甘油(polyglycerin)、水解的纖維連接蛋白(hydrolyzed fibronectin)、乳醯胺基MEA(lactamide MEA)、乳醯胺基-N-(2-羥基乙基)(lactamide N-(2-hydroxyetheryl))、甘露醇、甲基葡萄糖-10(methyl gluceth-10)、甲基葡萄糖-20、甲基矽烷PCA(methylsilanol PCA),泛醇(panthenol)、PCA、聚乙二醇 (PEG)、PEG-4、PEG-8、聚胺基蔗糖縮合物(polyamino sugar condensate)、季銨鹽-22(quaternium-22)、海鹽(sea salts)、癸醯乳醯乳酸鈉(sodium capryllactylate)、玻糖醛酸鈉(sodium hyaluronate)、異硬脂醯乳酸鈉(sodium isostearoyllactylate),sodium lactate)、月桂醯乳酸鈉(sodiumlauroyllactylate)、鈉PCA、聚谷氨酸鈉(sodium polyglutamate)、硬脂醯乙酸鈉(sodium stearoyllactylate)、可溶性膠原、去水山梨糖醇月桂酸酯(sorbitan laurate)、去水山梨糖醇油酸酯(sorbitanoleate)、去水山梨糖醇倍半油酸酯(sorbitansesquiisostearate)、去水山梨糖醇油酸酯(sorbitan stearate)、山梨糖醇、鞘脂類(sphingolipids)、TEA-PCA、乙二醇、二乙二醇(diethylene glycol)、三乙二醇(triethylene glycol)、及其他的聚乙二醇類、丙二醇、二丙二醇(dipropylene glycol),及其他的丙二醇類、1,3-丁二醇(1,3-butylene glycol)、1,4-丁二醇(1,4-butylene glycol)及其他的丁二醇類、甘油、二甘油及其他的多甘油類(polyglycerols)、甘露醇、木糖醇、麥芽糖醇及其他的蔗糖醇類(sugar alcohols)、乙氧基化(EO)及丙氧基化(PO)甘油加合物(glycerol ethylene oxide(EO)and propylene oxide(PO)adducts)、蔗糖醇EO及PO加合物、EO及PO與單糖(例如半乳糖及果糖)的加合物、EO或PO與多糖(如麥芽糖及乳糖)的加合物、吡咯烷酮羧酸鈉(sodium pyrrolidonecarboxylate)、甲基葡萄糖苷聚氧乙烯醚 (polyoxyethylene methyl glycoside)、聚乙二醇(polyethylene glycol)、丙二醇(propylene glycol)、二丙二醇(dipropylene glycol)、1,3-丁二醇(1,3-butylene glycol)、己二醇(hexylene glycol)、木糖醇、麥芽糖醇、D-甘露醇(D-mannitol)、麩質(gluten)、葡萄糖、果糖、乳糖、軟骨膠硫酸鈉(sodium chondroitin sulfate)、透明質酸鈉(sodium hyalonate)、磷酸腺苷鈉(sodium adenosine phosphate)、沒食子酸鹽(gallates)、吡咯烷酮羧酯(pyrrolidone carbonates)、葡萄糖胺、環糊精(cyclodextrin)、α羥基酸(alpha hydroxy acids)、2-甲基-1,3-丙基二醇(2-methyl-1,3-propane diol)、或其組合物。 Examples of suitable humectants include, but are not limited to: glycerin, hyaluronic acid, sorbitol, urea (urea), α-hydroxy acids (alpha hydroxy acids), sucrose (Sugars), lactic acid, propylene glycol, triacetin (glyceryl Polyacetate such as triacetate, lithium chloride, sorbitol, xylitol, and maltitol, polydextrose of polymeric polyols, Natural extracts of adipic acid, lactic acid, oleic acid, stearic acid, isostearic acid, myristic acid and linoleic acid saponin, hexadecyl ester, tetradecyl ester, isodecyl ester and isopropyl ester ( Quillaia, hexadecyl, myristyl, isodecyl and isopropyl esters of adipic, lactic, oleic, stearic, isostearic, myristic and linoleic acids) and many of its corresponding alcohol esters (eg sodium decyl-2-lactate) "sodium isostearoyl-2-lactylate", "sodium capryllactylate", hydrolyzed protein and other collagen-derived proteins, aloe vera gel, acetaminophen MEA, naturally occurring compounds on the stratum corneum of the skin, such as pyrrolidone Sodium pyrrolidone carboxylic acid, lactic acid, urea, L-valine, guanidine and pyrrolidone, acetamido MEA, acetamido propyl trimonium chloride, Calcium stearoyllactylate, chitosan pyrrolidone carboxylic acid (PCA), diglycerol lactate, ethyl ester of hydrolyzed silk, Fatty quaternary amine chloride complex, glycerrene-7, glycerol-12, glycerol-26, glycerol-4.5 lactate ), glycerin, diglycerin, polyglycerin, hydrolyzed fibronectin, lactamide MEA, lactam-N-(2-hydroxyethyl) (lactamide N-(2-hydroxyetheryl)), mannitol, methylgluceth-10, methyl glucose-20, methylsilanol PCA, panthenol, PCA, poly Ethylene glycol (PEG), PEG-4, PEG-8, polyamine Polyamino sugar condensate, quaternium-22, sea salts, sodium capryllactylate, sodium hyaluronate, isostearyl Sodium isostearoyllactylate, sodium lactate, sodium laurolaclate, sodium PCA, sodium polyglutamate, sodium stearoyllactylate, soluble collagen, sorbitan laurel Sorbitan laurate, sorbitanoleate, sorbitansesquiisostearate, sorbitan stearate, sorbitol, Sphingolipids, TEA-PCA, ethylene glycol, diethylene glycol, triethylene glycol, and other polyethylene glycols, propylene glycol, dipropylene glycol And other propylene glycols, 1,3-butylene glycol, 1,4-butylene glycol and other butanediols, glycerol, diglycerol And other polyglycerols ( Polyglycerols), mannitol, xylitol, maltitol and other sugar alcohols, ethoxylated (EO) and propoxylated (PO) glycerol adducts (EO) Propylene oxide (PO)adducts), sucrose alcohol EO and PO adducts, adducts of EO and PO with monosaccharides (such as galactose and fructose), adducts of EO or PO with polysaccharides (such as maltose and lactose) , sodium pyrrolidonecarboxylate, polyoxyethylene methyl glycoside, polyethylene glycol, propylene glycol, dipropylene glycol, 1,3- 1,3-butylene glycol, hexylene glycol, xylitol, maltitol, D-mannitol, gluten, glucose, fructose, lactose, cartilage Sodium chondroitin sulfate, sodium hyalonate, sodium adenosine phosphate, gallates, pyrrolidone carbonates, glucosamine, cyclodextrin Cyclodextrin, alpha hydroxy acid (alp Ha hydroxy acids), 2-methyl-1,3-propane diol, or a combination thereof.
該(f)保濕劑含量可以係該凝膠組成物總重計算的大於0至25、或1~15、1~10wt%。相似於其他成份,該(f)保濕劑在該凝膠組成物內的相對含量可基於數個因子來加以變動。 The (f) humectant content may be greater than 0 to 25, or 1 to 15, and 1 to 10% by weight based on the total weight of the gel composition. Similar to the other ingredients, the relative amount of the (f) humectant in the gel composition can be varied based on several factors.
在具體的實施例中,該凝膠組成物的(f)保濕劑包括一第一保濕劑及一第二保濕劑。即使是在這些實施例中,該(f)保濕劑也可包括該第一及第二保濕劑以外的保濕劑。在這些具體實施例中,該第一保濕劑包括甘油,及該第二保濕劑包括透明質酸鈉。該第一保濕劑典型地係以大於該第二保濕劑的數量來使用。例如,該第一保濕劑在該凝膠組成物內的含量係該凝膠組成物總重計算的1~15wt%,及該第二保濕劑的含量係大於0至1、或0.01~1wt%。當該第二保濕劑包括透明 質酸鈉時,該第二保濕劑在合併到該凝膠組成物之前,係可與水加以結合,其如下文所述。 In a specific embodiment, the (f) humectant of the gel composition comprises a first humectant and a second humectant. Even in these embodiments, the (f) humectant may include a humectant other than the first and second humectants. In these embodiments, the first humectant comprises glycerin, and the second humectant comprises sodium hyaluronate. The first humectant is typically used in an amount greater than the second humectant. For example, the content of the first humectant in the gel composition is 1 to 15% by weight based on the total weight of the gel composition, and the content of the second humectant is greater than 0 to 1, or 0.01 to 1% by weight. . When the second humectant includes transparency In the case of sodium sulphate, the second humectant can be combined with water prior to incorporation into the gel composition, as described below.
該凝膠組成物也包括(g)防腐劑。不同防腐劑的組合也可以共同使用來作為該(g)防腐劑。該凝膠組成物的(g)防腐劑並未加以限制。 The gel composition also includes (g) a preservative. Combinations of different preservatives can also be used together as the (g) preservative. The (g) preservative of the gel composition is not limited.
合適的防腐劑的例子包含葡萄籽提取物、對羥基苯甲酸甲酯(methylparaben)、對羥基苯甲酸丙酯(propylparaben)、重氮烷基脲(diazolindinyl urea)、山梨酸(sorbic acid)、苯氧乙醇(phenoxyethanol)、對羥基苯甲酸乙酯(ethylparaben)、對羥基苯甲酸丁酯(butylparaben)、對羥基苯甲酸丙酯鈉(sodium butylparaben)、辛乙二醇(caprylyl glycol)、脫氫醋酸(dehydroacetic acid)、氯苯甘油醚(chlorphenesin)、或任何的防腐劑。不同防腐劑的組合亦得以使用。 Examples of suitable preservatives include grape seed extract, methylparaben, propylparaben, diazolindinyl urea, sorbic acid, benzene. Phenoylethanol, ethylparaben, butylparaben, sodium butylparaben, caprylyl glycol, dehydroacetic acid (dehydroacetic acid), chlorphenesin, or any preservative. Combinations of different preservatives are also used.
在具體實施例中,該凝膠組成物的(g)防腐劑得為防腐劑預混合物。該防腐劑預混合物包括在一載具內的兩種或更多種防腐劑的組合。一個這類例子係包括在一載具內的氯苯甘油醚及對羥基苯甲酸甲酯的組合物(其每一者在防腐劑預混合物中的含量係該防腐劑預混合物總重計算的7.5wt%),該載具包括甘油及丁二醇的組合物(其每一在該防腐劑預混合物內的含量係以該防腐劑預混合物總重計算的42.5wt%)。 In a particular embodiment, the (g) preservative of the gel composition is obtained as a preservative premix. The preservative premix comprises a combination of two or more preservatives in a carrier. One such example is a composition comprising chlorophenyl glyceryl ether and methyl paraben in a vehicle (each of which is 7.5 in the preservative premix) based on the total weight of the preservative premix. Wt%), the vehicle comprises a composition of glycerin and butylene glycol (each of which is present in the preservative premix in an amount of 42.5 wt% based on the total weight of the preservative premix).
在具體的例子中,該(g)防腐劑在該凝膠組成物中的含量,係以該凝膠組成物總重計算的大於0至4、或1~4wt%。該(g)防腐劑在該凝膠組成物中的含量,得基於凝膠組成物內其他成份(包含可選用成份)的相對數量及選用而加以變動。當該防腐劑預混合物用來作為該(g)防腐劑時,該載具的重量,典型地係被包含在該凝膠組成物內該(g)防腐劑的相對數量之內。又,當該防腐劑預混合物係用來作為該(g)防腐劑時,該防腐劑預混合物得於該凝膠組成物現場形成,或可被提供或結合成為防腐劑預混合物。典型地,相對於當場形成的是,該凝膠組成物係與本身為獨立成份的防腐劑預混合物一起形成。 In a specific example, the (g) preservative is present in the gel composition in an amount of more than 0 to 4, or 1 to 4% by weight based on the total weight of the gel composition. The amount of the (g) preservative in the gel composition is varied based on the relative amount and selection of other ingredients (including optional ingredients) in the gel composition. When the preservative premix is used as the (g) preservative, the weight of the carrier is typically included within the relative amount of the (g) preservative within the gel composition. Also, when the preservative premix is used as the (g) preservative, the preservative premix is formed on site in the gel composition or may be provided or incorporated as a preservative premix. Typically, the gel composition is formed with a pre-preservative premix which is itself a separate component, as opposed to being formed on the spot.
該凝膠組成物進一步包括(h)中和劑。該(h)中和劑一般係用來中和該(d)稠化劑,尤其是該(d)稠化劑是酸類的時候,例如,丙烯酸聚合物。可替換的是,該中和劑可為一種緩衝劑,或可替換地被利用來修改該凝膠組成物的pH值。 The gel composition further includes (h) a neutralizing agent. The (h) neutralizing agent is generally used to neutralize the (d) thickening agent, especially when the (d) thickening agent is an acid, for example, an acrylic polymer. Alternatively, the neutralizing agent can be a buffer or alternatively utilized to modify the pH of the gel composition.
該(h)中和劑可為任何適用於中和酸類的化合物。一個合適的(h)中和劑的例子係,三醇胺(trialcoholamine),例如三乙醇胺(triethanolamine)。其他的合適的中和劑例子包含鹼性化合物,例如鹼金屬氫氧化物,如氫氧化鉀(KOH)、氫氧化鈉(NaOH)、及氫氧化銨(NH4OH)。如下文中相關於方法所描述者,在形成凝膠組成物時,該(h)中和劑係可以在(d)稠化劑之後,被安放至或添加到其他成份 內,以便防止過早的中和作用。 The (h) neutralizing agent can be any compound suitable for neutralizing acids. An example of a suitable (h) neutralizing agent is a trialcoholamine such as triethanolamine. Other suitable neutralizing agent examples include basic compounds such as alkali metal hydroxides such as potassium hydroxide (KOH), sodium hydroxide (NaOH), and ammonium hydroxide (NH 4 OH). As described below in relation to the method, the (h) neutralizing agent may be placed or added to other components after the (d) thickening agent, in order to prevent premature formation. Neutralization.
在許多實施例中,該(h)中和劑在該凝膠組成物中的含量係一觸媒數量,例如以該凝膠組成物總重為基礎計算的大於0至1、或0.05~1、或0.2~0.9、0.3~0.9wt%。該凝膠組成物內(h)中和劑的數量係可基於其他成份(包含可選用成份)的選用或相對數量來加以變動。如果(h)中和劑與(d)稠化劑進行反應,則如前文所述地的是,這些數量係以凝膠組成物的前反應或前中和作為基礎。 In many embodiments, the amount of the (h) neutralizing agent in the gel composition is a catalyst amount, for example, greater than 0 to 1, or 0.05 to 1 based on the total weight of the gel composition. , or 0.2~0.9, 0.3~0.9wt%. The amount of (h) neutralizing agent in the gel composition can be varied based on the choice or relative amount of other ingredients, including optional ingredients. If (h) the neutralizing agent is reacted with (d) the thickening agent, as described above, these amounts are based on the pre- or pre-neutralization of the gel composition.
可選用的是,該凝膠組成物可包含一或更多的額外成份,例如添加劑。合適的添加劑包含一般本項技藝人士所瞭解者,包含但不限於:油類、提取物、皮膚保護劑、消毒劑、殺菌劑、藥物及藥物類物質、止痛藥、抗氧化劑、防曬劑、驅蟲劑、去角質劑、芳香劑、染料、填料、溶劑、載具、本項技藝人士所知的其他類型的添加劑、以及其組合。這類添加劑係可單獨來使用,或組合起來使用。該凝膠組成物典型地具有一黏度,其隨著該凝膠組成物內成份相對數量或其選用而變動。 Alternatively, the gel composition may comprise one or more additional ingredients, such as additives. Suitable additives are generally known to those skilled in the art, including but not limited to: oils, extracts, skin protectants, disinfectants, bactericides, pharmaceutical and pharmaceutical substances, analgesics, antioxidants, sunscreens, flooding agents Insecticides, exfoliants, fragrances, dyes, fillers, solvents, vehicles, other types of additives known to those skilled in the art, and combinations thereof. Such additives can be used alone or in combination. The gel composition typically has a viscosity that varies with the relative amount of ingredients in the gel composition or its choice.
在某些實施例中,該凝膠組成物的黏度在25℃時,係至少10,000、可替換地至少20,000、至少30,000、至少40,000厘泊。例如,該凝膠組成物在25℃時的黏度,係20,000~150,000、或30,000~120,000、或40,000~80,000厘泊。該凝膠組成物典型地具有大於水的密度,例如大於1的比重。該 凝膠組成物典型地pH範圍係5~7、或5.7~6.6。pH值可藉由併入選用成份來修改,及藉由修改(例如)(h)中和劑的相對數量來修改。 In certain embodiments, the gel composition has a viscosity of at least 10,000, alternatively at least 20,000, at least 30,000, at least 40,000 centipoise at 25 °C. For example, the gel composition has a viscosity at 25 ° C of 20,000 to 150,000, or 30,000 to 120,000, or 40,000 to 80,000 centipoise. The gel composition typically has a density greater than water, such as a specific gravity greater than one. The The gel composition typically has a pH range of 5-7, or 5.7-6.6. The pH can be modified by incorporating optional ingredients and modified by modifying, for example, (h) the relative amount of neutralizing agent.
凝膠組成物內成份相對數量的修改,產生了凝膠組成物的結果物理性質,因此,該凝膠組成物能夠有利地加以改質或最佳化。 Modification of the relative amounts of the components within the gel composition results in the resulting physical properties of the gel composition and, therefore, the gel composition can advantageously be modified or optimized.
該凝膠組成物具有優良的物性,及非常適用於多種最終用途及應用,尤其是超音波程序。該凝膠組成物係非流動性的(non-runny),及在主體係垂直站立或處於水平基材上時,可被施加到主體皮膚上,而不會流動或滴落。如此,該凝膠組成物係特別地適合超音波程序,而不管主體是否處在水平(躺平)或垂直位置上,其如下文所述。該凝膠組成物也具有優良的聲學性質,在超音波操作期間不會干擾到聲波。再者,該凝膠組成物具有優良的潤滑性質,因此可以作為吾人想要的界面,介於該主體皮膚及儀器(如超音波探針或換能器)之間。然而,該凝膠組成物並非如此地來限制,及也可在超音波程序以外的最終應用中加以使用。例如,該凝膠組成物可獨立於超音波程序而擦拭在及/或到皮膚上。 The gel composition has excellent physical properties and is well suited for a variety of end uses and applications, especially ultrasonic procedures. The gel composition is non-runny and can be applied to the subject's skin without flowing or dripping when the primary system stands vertically or on a horizontal substrate. As such, the gel composition is particularly suitable for ultrasonic procedures, regardless of whether the body is in a horizontal (lying flat) or vertical position, as described below. The gel composition also has excellent acoustic properties that do not interfere with sound waves during ultrasonic operation. Furthermore, the gel composition has excellent lubricating properties and thus can serve as the interface we desire between the subject skin and the instrument (such as an ultrasonic probe or transducer). However, the gel composition is not so limited and can also be used in end applications other than ultrasonic procedures. For example, the gel composition can be wiped onto and/or onto the skin independently of the ultrasonic procedure.
本發明也提供一種凝膠組成物的製備方法(製備方法)。該製備方法包括:組合該(a)載體,(b)螫合劑,(c)抗發炎劑,(d)稠化劑,(e)皮膚調理劑,(f)保濕劑,(g)防腐劑;及(h)中和劑,以便製備該凝膠組成物。 The present invention also provides a method for preparing a gel composition (preparation method). The preparation method comprises: combining the (a) carrier, (b) a chelating agent, (c) an anti-inflammatory agent, (d) a thickening agent, (e) a skin conditioning agent, (f) a moisturizing agent, (g) a preservative And (h) a neutralizing agent to prepare the gel composition.
該成份可在該製備方法中以任何順序來組合,可選用地是,在剪斷力或攪伴之下進行。個體成份可選用地連同另一成份來組合,而在形成該凝膠組成物之前,形成多種”預混合物”成份。在製備凝膠組成物時,該載體係可逐漸加量地添加。附帶於製備方法的條件可依照吾人所想要的來修改,例如,相關於溫度、相對濕度等等。如本項技藝人士所瞭解的,該方法所附帶的參數(包含溫度、時間),係可基於製造體積及其他因子,在許多方法下增加或減少規模而加以變動。 The ingredients may be combined in any order in the preparation process, optionally in the presence of shearing forces or agitation. The individual ingredients are optionally combined with another ingredient to form a plurality of "premix" ingredients prior to forming the gel composition. When preparing the gel composition, the carrier can be added in an incremental manner. The conditions attached to the preparation method can be modified as desired, for example, in relation to temperature, relative humidity, and the like. As will be appreciated by those skilled in the art, the parameters (including temperature, time) attached to the method can be varied based on manufacturing volume and other factors, increasing or decreasing in size under a number of methods.
在該製備方法的具體實施例中,某部份的(a)載體係首先安置在一容器內,連同(b)螫合劑及(c)抗發炎劑處於混合之下形成一混合物,及該(d)稠化劑係遞增地置入該混合物中,形成一稠化的混合物。一般而言,該(d)稠化劑係以一個速率逐漸加量地添加到混合物中,避免凝聚或結塊。該(a)載體在該混合物中的使用數量,係得以變動,但典型地係小於該凝膠組成物中(a)載體總量的一半。當該(d)稠化劑遞增地被添加到混合物中時,該(d)稠化劑可以吸收混合物內一部份的(a)載體,及當(d)稠化劑被遞增地置入該混合物中,一直到與(a)載體水合時為止,該混合物被剪斷或攪拌。該混合物及該稠化的混合物均典型地加以混合,以致於該混合物及該稠化的混合物係均質的,(雖然該混合物及該稠化的混合物可選用地及獨立地是異質的。 In a specific embodiment of the method of preparation, a portion of the (a) carrier is first disposed in a container, and (b) a chelating agent and (c) an anti-inflammatory agent are mixed to form a mixture, and d) A thickening agent is incrementally placed into the mixture to form a thickened mixture. In general, the (d) thickening agent is added to the mixture at a rate that is gradually added to avoid agglomeration or agglomeration. The amount of the (a) carrier used in the mixture is varied, but is typically less than half of the total amount of the carrier (a) in the gel composition. When the (d) thickening agent is incrementally added to the mixture, the (d) thickening agent can absorb a portion of the (a) carrier in the mixture, and when (d) the thickening agent is incrementally placed The mixture is sheared or stirred until the (a) carrier is hydrated. Both the mixture and the thickened mixture are typically mixed such that the mixture and the thickened mixture are homogeneous (although the mixture and the thickened mixture are optionally and independently heterogeneous.
在這些製備方法具體實施例中,額外數量的(a)載體及(e)皮膚調理劑,被安放在稠化混合物中,形成了第一組成物。如前文所述,該(e)皮膚調理劑可包括多數個相配的皮膚調理劑,及這類多數個皮膚調理劑,在形成第一組成物時,典型地共同地(或依序地)被置入稠化的混合物中。例如,每一種皮膚調理劑係可以獨立地被置入該稠化中的混合物內,或每一個皮膚調理劑係結合額外數量的(a)載體,以致於該額外數量的(a)載體及該(e)皮膚調理劑係共同地被置入該稠化的混合物中。 In a specific embodiment of these methods of preparation, an additional amount of (a) a carrier and (e) a skin conditioning agent are placed in the thickened mixture to form a first composition. As described above, the (e) skin conditioning agent can include a plurality of matching skin conditioning agents, and such a plurality of skin conditioning agents, typically collectively (or sequentially) when formed into the first composition. Place in the thickened mixture. For example, each skin conditioning agent can be independently placed into the thickened mixture, or each skin conditioning agent can be combined with an additional amount of (a) carrier such that the additional amount of (a) carrier and (e) Skin conditioning agents are commonly placed in the thickened mixture.
再者,在這些製備方法具體實施例中,該第一組成物係加熱至上升的溫度一段時間。該上升的溫度典型地係小於(a)載體及第一組成物的沸點。典型地,該上升的溫度係50~100、或60~90、75~80℃。當(e)皮膚調理劑包括(例如)化粧蠟(可能有上升的熔點溫度)時,經常要利用到該上升溫度。該段時間典型地係大於0到60、或5~20、或10~15分鐘。在加熱該第一組成份至上升溫度該段時間之後,該第一組成份通常加以冷卻至小於該上升溫度的溫度,如30~60、或40~45℃。該第一組成物係可以主動地冷卻至這個溫度,或謹謹暫停加熱,以致於該第一組成物係在周圍條件的天然冷卻之下,抵達這個溫度。 Further, in these embodiments of the preparation method, the first composition is heated to a rising temperature for a period of time. The elevated temperature is typically less than (a) the boiling point of the support and the first composition. Typically, the elevated temperature is 50 to 100, or 60 to 90, and 75 to 80 °C. When the (e) skin conditioning agent includes, for example, a cosmetic wax (which may have an elevated melting point temperature), the elevated temperature is often utilized. This period of time is typically greater than 0 to 60, or 5 to 20, or 10 to 15 minutes. After heating the first component to the elevated temperature for a period of time, the first component is typically cooled to a temperature less than the elevated temperature, such as 30 to 60, or 40 to 45 °C. The first composition can be actively cooled to this temperature, or the heating should be suspended so that the first composition reaches this temperature under natural cooling of ambient conditions.
此外,在這些製備方法具體實施例中,該(g)防腐劑及該(h)中和劑係被置入該第一組成物中,形成該凝膠組成 物。該第一組成物,當其中置入(h)中和劑時,典型地被稠化了。典型地,該第一組成份係在(h)中和劑添加期間被混合,並未合併任何過量的空氣。該混合可在惰氣條件下或在真空之下進行。 Further, in a specific embodiment of the preparation method, the (g) preservative and the (h) neutralizing agent are placed in the first composition to form the gel composition. Things. The first composition, when the (h) neutralizing agent is placed therein, is typically thickened. Typically, the first component is mixed during the (h) neutralizer addition without any excess air being combined. This mixing can be carried out under inert gas conditions or under vacuum.
在某些實施例中,當(f)保濕劑包括玻糖醛酸鈉時,不論是單獨地或連同其他保濕劑,該玻糖醛酸鈉係在其與其他成份結合來形成凝膠組成物之前,與某些(a)載體加以結合。 In certain embodiments, when (f) the humectant comprises sodium gluconate, either alone or in combination with other humectants, the sodium gluconate is combined with other ingredients to form a gel composition. Previously, it was combined with some (a) carriers.
又,本發明提供一種該凝膠組成物應用到超音波程序的方法(應用方法)。該應用方法包括:施加該凝膠組成物至主體皮膚上。該凝膠組成物可透過任何方式,被塗抹或擦拭到皮膚上,及可從皮膚上擦掉,或在超音波程序之外被塗抹在/到皮膚上。 Further, the present invention provides a method (application method) of applying the gel composition to an ultrasonic program. The method of application includes applying the gel composition to the subject's skin. The gel composition can be applied or wiped onto the skin by any means, and can be rubbed off the skin or applied to/on the skin outside the ultrasonic procedure.
在皮膚上施加凝膠組成物,係可藉由任何的技術來執行。例如,該凝膠組成物可以謹謹地由主體來施加到皮膚上,或由其他人來施加。該凝膠組成物可被分配、灑佈及/或施加到皮膚上,可選用的是,同時可施加一外力來灑佈或施加該凝膠組成物。在某些實施例中,該基材也可以採用一個物品的形式,來承載或輸送該凝膠組成物到主體的皮膚上。這些步驟係可依照所想要的來重複多次,以便取得所想要的利益。 Applying a gel composition to the skin can be performed by any technique. For example, the gel composition can be applied to the skin by the body or applied by others. The gel composition can be dispensed, sprinkled and/or applied to the skin, optionally with the application of an external force to spread or apply the gel composition. In certain embodiments, the substrate can also be in the form of an article to carry or transport the gel composition onto the skin of the subject. These steps can be repeated as many times as desired to achieve the desired benefit.
該凝膠組成物具有優良的超音波及潤滑性質,及 特別地適用於超音波程序。在這類程序中,該凝膠組成物係在一個界面上,其介於皮膚與一超音波探針或換能器之間,被施加到主體皮膚上。聲波經由該凝膠組成物來傳送,及可被利用來(例如)成像或製圖,或用來處理皮膚症狀。在具體實施例中,該凝膠組成物係可利用於超音波程序中,以便降低皺紋、或改善主體(例如)臉部及/或頸部的皮膚症狀。 The gel composition has excellent ultrasonic and lubricating properties, and Especially suitable for ultrasonic programs. In such procedures, the gel composition is applied to an interface between the skin and an ultrasonic probe or transducer and applied to the subject's skin. Sound waves are delivered via the gel composition and can be utilized, for example, for imaging or mapping, or for treating skin conditions. In a particular embodiment, the gel composition can be utilized in an ultrasonic procedure to reduce wrinkles or to improve skin conditions of the subject, for example, the face and/or neck.
基於該凝膠組成物的優良物性,該凝膠組成物可以在主體處於站立或坐下時來施加,不會有令人不想要的流動或分離。對照之下,許多習知的超音波凝膠係在主體水平躺下時來施加,以便防止重力引起該習知超音波凝膠產生令人不想要的流動。此外,該凝膠組成物,基於,係對皮膚有益。 Based on the excellent physical properties of the gel composition, the gel composition can be applied while the body is standing or sitting without undesired flow or separation. In contrast, many conventional ultrasonic gels are applied while the subject is lying down horizontally to prevent gravity from causing the conventional ultrasonic gel to produce unwanted flows. Furthermore, the gel composition, based on, is beneficial to the skin.
下述的例子係意圖說明目前的實施例,任絕不可視為實施例範圍之限制。 The following examples are intended to illustrate the present embodiments and are not to be considered as limiting the scope of the embodiments.
例一:凝膠組成物Example 1: Gel composition
一凝膠組成物係依照現有實施例來製備。下文中的表一列出被使用來製備該凝膠組成物的成份及其相對數量。 A gel composition was prepared in accordance with the prior embodiments. Table 1 below lists the ingredients used to prepare the gel composition and their relative amounts.
載體(第一、二及三部)係水。 The carrier (first, second and third) is water.
螫合劑包括鈉EDTA。 The chelating agent includes sodium EDTA.
抗發炎劑包括甘草酸二鉀。 Anti-inflammatory agents include dipotassium glycyrrhizinate.
稠化劑包括一丙烯酸聚合物。 The thickener comprises an acrylic polymer.
皮膚調理劑1包括丁二醇。 Skin Conditioning Agent 1 comprises butylene glycol.
保濕劑1包括甘油。 Humectant 1 includes glycerin.
皮膚調理劑2包括雙PEG-18-甲基醚二甲基矽烷蠟。 Skin Conditioning Agent 2 comprises a diPEG-18-methyl ether dimethyl decane wax.
皮膚調理劑3包括聚乙二醇(7)甘油椰油酸酯。 Skin Conditioner 3 includes polyethylene glycol (7) glyceryl cocoate.
防腐劑包括在一載具內的氯苯甘油醚/對羥基苯甲酸甲酯的防腐劑預混合物,該載具包括甘油及丁醇的混合物。 The preservative comprises a preservative premix of chlorophenyl glyceryl ether/methylparaben in a vehicle comprising a mixture of glycerol and butanol.
中和劑係三乙醇胺。 The neutralizing agent is triethanolamine.
皮膚調理劑4包括生物糖膠-1。 Skin Conditioner 4 includes Biosaccharide-1.
保濕劑2包括玻糖醛酸鈉。 Humectant 2 includes sodium sodium carboxylate.
在該方法中,該載體、螫合劑、及抗發炎劑,係在攪拌下於一容器內加以結合。調稠化劑係逐漸加量地被添加到該容器內,一直到水合為止。該載體(第二部)、皮膚調理劑1、保濕劑1、皮膚調理劑2、及該皮膚調理劑3,被置入該容器內。在攪拌容器內含成份的同時,該容器加熱至一提升的溫度75~80℃持續約10~15分鐘。然後,容器的內含成份被冷卻至約40~45℃。在這個溫度時,將防腐劑及中和劑混合至該容器內含成份中,不要合併空氣進去。該載體(第三部)係與該保濕劑2結合成為一預混合物,及該預混合物係在連同皮膚調理劑4一起攪拌之下,被放入該容器之內,以便形成該凝膠組成物。 In this method, the carrier, chelating agent, and anti-inflammatory agent are combined in a container under agitation. The thickening agent is gradually added to the container until it is hydrated. The carrier (second part), skin conditioning agent 1, moisturizer 1, skin conditioning agent 2, and the skin conditioning agent 3 are placed in the container. While stirring the contents of the container, the container is heated to an elevated temperature of 75 to 80 ° C for about 10 to 15 minutes. The contents of the container are then cooled to about 40 to 45 °C. At this temperature, preservatives and neutralizers are mixed into the contents of the container. Do not incorporate air into it. The carrier (third portion) is combined with the humectant 2 to form a premix, and the premix is placed in the container with agitation together with the skin conditioner 4 to form the gel composition. .
該凝膠組成物的黏度係53,504厘泊周圍條件(即25℃),比重為1.019,及pH值係6.30。 The gel composition had a viscosity of 53,504 centipoise (i.e., 25 ° C), a specific gravity of 1.019, and a pH of 6.30.
該字詞”包括cormprising”或”包括comprise”,在本文中係以最廣意義加以使用,以表示及涵蓋”包含including”、” 包含include”、”基本上由...組成consist(ing)essentially of”、及”由...組成consist(ing)”的觀念。使用”例如for example”、”例如e.g.”、”例如such as”、及”包含”等語詞,來列出說明性範例時,並不只局限於所列出範例而已。因此,”例如for example”或”例如such as”,係表示”例如,但不局限在”,或”例如,但不限於”,且涵蓋了其相類似或等價的例子。在本文中所使用的字詞”約”,用來合理地涵蓋或描述藉由儀器分析或樣品處理結果所測得之數值的小變型。這樣的小變型可能係在該數值的±0~10、±0~5、或±0~2.5%之順序內。又,該字詞”約”,均適用於附帶一值範圍的數字值。再者,該字”約”,在沒有明顯陳述下,也可適用於數字值。 The word "including cormprising" or "comprises" is used in its broadest sense to mean and encompass "including"," Contains the concept of "include", "consisting essentially of "consist (ing) essentially of", and "consisting of "consist(ing)". Use "for example", "eg eg", "such as The terms "as" and "including" are used to list the illustrative examples and are not limited to the examples listed. Therefore, "for example" or "such as such as" means "for example, but not limited. The word "or" is used, for example, but not limited to, and encompasses similar or equivalent examples. The word "about" as used herein is used to reasonably encompass or describe by instrumental analysis or sample processing. A small variation of the measured value. Such a small variant may be in the order of ±0~10, ±0~5, or ±0~2.5% of the value. Again, the word "about", Applicable to numerical values with a range of values. Furthermore, the word "about" can also be applied to numerical values without being explicitly stated.
一般而言,本文中被使用於數值範圍內的連接符號”-“、或破折號”__”,係指”到”或”直到”;”>”係指”高於”或”大於”;”≧”係”至少”或”大於等於”;”<”係”低於”或”小於”;”≦”係”最多”或”小於等於”。在個體的基礎之下,前述針對”專利”或”專利申請公開”的每一個應用,係公開地合併在本文,以便在一或更多非限制性實施例中,整體地來參考。 In general, the connection symbol "-" or "dash" __" used in the numerical range herein refers to "to" or "until"; ">" means "above" or "greater than"; "≧" is at least "or" greater than or equal to; "<" is lower than "or less than"; "≦" is "maximum" or "less than or equal to". Each of the aforementioned applications for "patent" or "patent application disclosure" is hereby incorporated by reference in its entirety in its entirety in its entirety in its entirety in its entirety in its entirety in its entirety herein
要瞭解的是,後附的申請專利範圍,並不限制於表達或特指一些在說明書中詳述的化合物、組成物或方法,其在符合後附權利申請項之特定實施例之間係可有變動。關於在本文中用來描述諸實施例之特定特色或觀點的、不同 的、特別的、及\或非預期結果的馬庫西群組,得自每一馬庫西群組中的每一數字加以取得,其係獨立於其他全部的馬庫西數字。馬庫西群組的每一個數字,均可獨立地使用,或加以組合,及其對於後附權利項範圍內的具體實施例提供了充足的支持。 It is to be understood that the scope of the appended claims is not to be construed as limited or There are changes. Different from the specific features or viewpoints used to describe the embodiments herein. The Markusi group of special, and/or unexpected results, obtained from each of the numbers in each of the Markusi groups, is independent of all other Markusi numbers. Each number of the Markusi group can be used independently or in combination, and it provides sufficient support for the specific embodiments within the scope of the appended claims.
又,任何範圍及次範圍,係被依附來獨立地或集體地描述後附權利項範圍內現有實施例的多數個實施例,及係被瞭解為描述或考慮包含其體及/或部份值的全部範圍,儘管這類值並未明白地書寫本中時亦然。一般熟習本項技藝之士能輕易地認同的是,數字範圍及次範圍係足以描述本發明諸多實施例並其成為可能,及這類範圍和次範圍係進一步地劃分成為相關的一半、三分之一、四分之一、五分之一等等。例如(謹作為示範),”0.1~0.9”的範圍,可以進一步地劃分成為較少的三分之一,即0.1~0.3,中間的三分之一,即0.4-0.6,及較多的三分之一,即0.7~0.9,這些係各自地或集體地落入後附權利項範圍之內,及係可以各自地或集體地依附,並且對於後附權利範圍內的具體實施例,提供足夠的支持。此外,關於一些被用來定義或修飾一個範圍的語詞,例如”至少”、”大於”、”小於”、”不多於”、及相似之類等等,要瞭解的是,這類語詞包含次範圍及/或較高的或較小的限制。如另一個例子,”至少10”這個範圍,本有地包含一至少10~35次範圍,一10~25次範圍,一25~35次範圍等等,及每 一個次範圍均得獨立地或集體地被依附,並對於後附權利項範圍內的具體實施例提供充足的支持。最後,在所示範圍內的個體數字,係得以依附,及對於後附權利項範圍內的具體實施例提供充足的支持。例如,一1~9的範圍,包含許多個體整數,如3,以及包含有小數點(或分數)的個體數字,如4.1,其皆可對於後附權利項範圍內的具體實施例提供充足的支持。 Further, any range and sub-range are singularly or collectively describing a plurality of embodiments of the present embodiments within the scope of the appended claims, and are understood as describing or considering the inclusion of the body and/or partial values. The full range, although such values are not clearly written in the text. It is readily recognized by those skilled in the art that the numerical ranges and sub-ranges are sufficient to describe and enable the various embodiments of the present invention, and such ranges and sub-ranges are further divided into related half and three points. One, one quarter, one fifth, and so on. For example (for demonstration purposes), the range of "0.1~0.9" can be further divided into a smaller one, ie 0.1~0.3, the middle third, ie 0.4-0.6, and more three One or more, that is, 0.7 to 0.9, which are individually or collectively within the scope of the following claims, and which may be individually or collectively attached, and provide sufficient for specific embodiments within the scope of the appended claims. support. In addition, with respect to some words used to define or modify a range, such as "at least", "greater than", "less than", "not more than", and the like, it is to be understood that such words include Sub-range and/or higher or smaller limits. As another example, the range of "at least 10" includes a range of at least 10 to 35 times, a range of 10 to 25 times, a range of 25 to 35 times, etc., and each Each of the sub-ranges is dependent on the individual or collectively and provides sufficient support for the specific embodiments within the scope of the appended claims. Finally, individual numbers within the scope of the disclosure are attached and sufficient support is provided for the specific embodiments within the scope of the appended claims. For example, a range of 1-9, including a number of individual integers, such as 3, and individual numbers containing decimal points (or fractions), such as 4.1, may provide sufficient for specific embodiments within the scope of the appended claims. stand by.
本發明現有實施例已於本文中以說明性的方式來描述,及要瞭解的是,已使用的命名方法係企圖落於該描述文字的本質之內,而不是做為限制。本發明許多修改及變型,基於前述教示之下,係有可的。現有的實施,除了具體明示於後附權利項範圍者外,也得以施行。權利範圍之獨立項及依附項的全部組合主體,不管其是單一依附或者多重依附,均係本文中明白地可以思及的。 The present invention has been described in an illustrative manner, and it is understood that the naming method used is intended to be within the spirit of the description and not to be construed as limiting. Many modifications and variations of the present invention are possible based on the foregoing teachings. Existing implementations can be implemented in addition to those specifically set forth in the appended claims. The independent subject matter of the scope of rights and the entire combination of the dependent items, whether single or multiple, are clearly understood in this document.
Claims (16)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562258090P | 2015-11-20 | 2015-11-20 | |
| US201662339299P | 2016-05-20 | 2016-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW201718031A true TW201718031A (en) | 2017-06-01 |
Family
ID=57485919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW105137601A TW201718031A (en) | 2015-11-20 | 2016-11-17 | Gel composition for ultrasound procedure and related methods |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW201718031A (en) |
| WO (1) | WO2017087606A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019173486A1 (en) * | 2018-03-06 | 2019-09-12 | University Of Maryland, Baltimore | Thermo-responsive ultrasound coupling gel, and methods and uses thereof |
| MX2020010161A (en) * | 2018-04-06 | 2020-10-22 | Philip Morris Products Sa | Nicotine gel. |
| JP2025083952A (en) * | 2023-11-21 | 2025-06-02 | 富士フイルム株式会社 | Acoustic matching member and medical image capturing method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8133516B2 (en) * | 2008-10-31 | 2012-03-13 | Lauer Scott D | Therapeutic ultrasound gel |
| US9801900B2 (en) * | 2013-11-22 | 2017-10-31 | Mary Kay Inc. | Compositions for sensitive skin |
-
2016
- 2016-11-17 WO PCT/US2016/062416 patent/WO2017087606A1/en not_active Ceased
- 2016-11-17 TW TW105137601A patent/TW201718031A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017087606A1 (en) | 2017-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20170143855A1 (en) | Gel composition for ultrasound procedure and related methods | |
| CN105209008B (en) | Skin cleaner | |
| KR101110454B1 (en) | Composition | |
| CN104173203B (en) | Low-irritation skin massage product | |
| CN104955440A (en) | Cosmetic additive and cosmetic containing same | |
| US20060127458A1 (en) | Single use personal care sheet | |
| JP6081159B2 (en) | Cleaning agent and manufacturing method thereof | |
| CN104263566A (en) | Multifunctional cleaning cream for stain removal and sterilization and preparation method thereof | |
| CN110090182A (en) | A kind of mild bath oil and preparation method thereof | |
| CN109010243A (en) | A kind of moisturizing essence | |
| TW201718031A (en) | Gel composition for ultrasound procedure and related methods | |
| CN106551819B (en) | A kind of microemulsion composition with high oil content, preparation method and application thereof | |
| CN103764116B (en) | Comprise skin and the hand cleaning agent of high-hydroscopicity granule | |
| CN111773141A (en) | Washing and discharging two-in-one composition and preparation method thereof | |
| JP5885938B2 (en) | Body wash cosmetics | |
| US8728448B2 (en) | Use of agglomerated hydroxyethylcellulose in pharmaceutical, personal care and household care applications | |
| JPH08199190A (en) | Liquid composition for producing foam-containing lump | |
| JP2544102B2 (en) | Weakly acidic bath salt | |
| CN106366207A (en) | Fenugreek water-soluble polysaccharide hand sanitizer and preparation method thereof | |
| DE102020215081B4 (en) | Powdered cosmetic cleaning agent | |
| JP2017507974A (en) | Shellac-based skin care lotion | |
| JP2000026238A (en) | Jelly cleansing cosmetic | |
| JPH04100535A (en) | Oil in polyhydric alcohol type emulsified composition | |
| JP3587701B2 (en) | Composition for moisturizing and composition for external use of skin containing the same | |
| JP3535985B2 (en) | Cosmetic pack and method for producing the same |